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Abstract 
 
 
 
This research focuses on the smoking rates among the Active Duty Air Force 
(ADAF) personnel and the association of smoking and cost of hospitalization because 
of diseases related to smoking. The analysis of the data taken from the Air Force Web 
HA questionnaire provides information about the relationship between the smoking 
rates of the ADAF personnel and specific socio-demographic characteristics. The 
analysis of a second dataset associated with the cost of hospitalization, provides a list 
with the most prevalent diseases related to smoking w th the highest cost. Moreover, a 
Regression Analysis tries to explore potential predictors that could anticipate the cost 
of the most prevalent diseases related to smoking.  
The Contingency Analysis showed that smoking in the U.S. Air Force is more 
prevalent among the enlisted, males, and the younger age groups. The Pivot Table 
Analysis demonstrated that ischemic heart disease and cerebrovascular disease present 
the highest cost. In addition, the enlisted personnel exhibit  higher total cost compared 
to the officers, but the situation is reversed when referring to the average cost. 
Furthermore, while smoking is more prevalent among the younger age groups, the 
cost consequences of smoking are more intense in th older age groups.  The 
Regression Analysis exhibited that the variables, rlated to socio-demographic 
characteristics, that explain better the cost of hospitalization are the age group of 45-
60, the enlisted personnel, and all the pay ranks of the officers, while the diseases that 
affect more the cost of hospitalization are ischemic heart disease, cerebrovascular 
disease, malignant neoplasms of the urinary bladder, and other arterial diseases.  
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1 
SMOKING IN THE UNITED STATES AIR FORCE: TRENDS, MOST 
PREVALENT DISEASES AND THEIR ASSOCIATION WITH COST 
 
                  I .  Introduction 
Background  
 
 Smoking is undoubtedly one of the most severe and serious social issues, and 
scientists and sociologists talk about it as a social phenomenon that affects various 
fields of human activity. Smoking is not merely a personal choice at the individual 
level, but affects society and thereby has become a public and social phenomenon. 
Smokers frequently face serious diseases that oftenlead to death such as lung cancer, 
pancreatic cancer, kidney cancer, emphysema, chronic bronchitis, coronary heart 
disease and cerebrovascular disease. 
Smoking is a harmful habit not just for the smoker, but also for the other 
people surrounding the smoker. The detrimental effects of second-hand smoke include 
coughing, headaches, sore throat, eye irritation and dizziness. In addition, the 
dangerous effects that smoking can have on pregnant women and newborn babies 
cannot be ignored. Women who smoke are approximately 30% more likely to 
experience infertility than other women.  Also, women who continue smoking while 
they are pregnant are twice as likely to have problems with their pregnancies in the 
third trimester (Diwan, 2010).  
 Even though anti-smoking campaigns have increased significantly in recent 
years and there are no more advertisements or billboards promoting smoking, the 
number of smokers increases every year and, accordingly, the number of deaths 
caused by the harmful effects of smoking (Mallin, 200 ). “Smoking is the leading 
preventable cause of death in the U.S. More than 400,00  people die each year due to 
2 
smoking, with $167 billion spent in annual health-related economic losses” (Smith et 
al., 2008).  The health consequences of smoking result in a substantial economic toll 
on people, employers, and society. Smoking results in cost effects that account for 
billions of dollars in annual medical care expenditures. The cost effects attributable to 
smoking include: cost of hospitalization, cost of physician visits, partial income loss 
due to disability and foregone future income due to premature death.  
Problem Statement  
 Smoking among the active duty members of the U.S. military is one of the 
most alarming problems. Tobacco use by military personnel is an increasingly 
upsetting issue, because tobacco use can affect the alertness and readiness of troops 
during their deployment, and the general image and effectiveness of the military. 
Recent reports suggest that smoking has become more popular among those on active 
duty and especially those deployed in battlefields (Emanuel, 2010).  At least one in 
three service members is a tobacco user of some sort, according to the Institute of 
Medicine (IOM) study (Emanuel, 2010).  This number comes higher when referring 
to those service members that are engaged in combat operations (Emanuel, 2010). 
Since smoking is clearly an issue that concerns the military, the government has 
implemented many measures in the past and continues to do so, in an effort to reduce 
smoking rates and eliminate tobacco use among its members. The Department of 
Defense (DoD), under the Health Promotion Policy Directive 1010.10 initiated in 
1986, tried to improve and maintain the readiness and the quality of life of DoD 
personnel by replacing the Directive 6015.18, "Smoking in DoD Occupied Buildings 
and Facilities", and establishing a policy on smoking in DoD buildings and facilities 
(Arvey and Malone, 2008). Directive 1010.10 was more than a mere educational 
program and included restrictions concerning tobacco use. Directive 1010.10 also 
3 
included education and detailed information on the health effects and risks of 
smoking, aiming to prevent personnel from smoking ad, in this way, enhancing their 
quality of life. Although Directive 1010.10 was extnded in 1994 by Directive 
1010.15 and implemented restrictions on indoor smoking, the tobacco control policy 
in DoD has largely remained unchanged, with smoking rates among active duty 
members of the U.S. military remaining high (Arvey and Malone, 2008).  
 The prevalent social problem of smoking in the U.S. military brings about a lot 
of consequences such as the aggravation of the DoD healthcare budget, the 
deterioration of military fitness levels and the mitigation of deployment readiness. 
Tobacco costs the Defense Department more than $1.6 billion a year in medical care 
and lost work days. The Pentagon laid out a plan in 1999 to reduce smoking rates by 
5% a year by 2001, and could not achieve that goal (Riechman, 2009).  Military 
tobacco users have been found to be more likely to have injuries during their training 
and have a higher probability of discharge within te first year of their service, 
compared to non smoking personnel (Klesges et al., 2001).  In addition, tobacco users 
miss part of their training or miss duty days far more frequently than their non-
smoking cohorts because of an illness related to smoking or aggravated because of 
smoking (Klesges et al., 2001).  Those military personnel who smoke tend to be less 
productive and do not perform satisfactorily on physical tests relative to their non 
smoking colleagues (Conway and Cronan, 1988).  A study hat measured the factors 
affecting the performance of the physical fitness tests among the military population 
indicated that smoking was a more potent and firmer pr dictor of physical fitness than 
weight (Haddock et al., 2007).  
 Tobacco use includes the utilization of cigarettes, cigars, pipe tobacco and oral 
tobacco forms such as chew, snuff, dip and snooz. The main addictive substance in 
4 
tobacco is nicotine, which could be considered dangerous, as it is an addictive drug in 
any form. And like other addictive substances, it creates dependence and subsequently 
unpleasant withdrawal symptoms. Researchers have pro n that the pharmacologic 
and behavioral characteristics that designate nicoti e addiction are similar to the 
addiction that drugs such as heroin and cocaine provoke (American Heart 
Association, 2010). An addiction consists of the good feelings that result when an 
addictive substance is present and the bad feelings when it is not present, and nicotine 
addiction creates exactly the same symptoms, being one of the hardest addictions to 
break. Tobacco use and in the same sense nicotine use, create serious diseases and 
increases the risk of developing hardened arteries and heart attacks (American Heart 
Association, 2010).  
Despite the vast research on the phenomenon of smoking and the heightened 
awareness of its detrimental effects upon health, society and government, and the 
noticeable publicity about litigation against tobacco companies, statistics indicate that 
the percent of adults who smoke in the United States increases every year, with a 
more pointed increase in smoking among persons 18 to 24 years of age (Mallin, 
2002). After a 40-year decline, the U.S. smoking rate has fluctuated around 20% since 
2005.  Nearly 47 million adults make use of tobacco and the majority of them are 
male smokers and people living under the poverty level. (American Council for Drug 
Education, 2010).  
 Another severe problem associated with smoking and use of tobacco is the 
passive or environmental tobacco smoke (ETS), more c mmonly known as 
secondhand smoke. Demographics have shown that between 70% and 90% of non-
smokers in the United States population are subject to secondhand smoke (University 
of Minnesota, 2010). It has been estimated that from the smoke emitted from one 
5 
cigarette, only 15% is inhaled by the smoker and the remaining 85% is released into 
the air for everyone to inhale. According to one study, secondhand smoke is the third 
leading preventable cause of death and disability in he United States after active 
smoking and alcohol use (University of Minnesota, 2010).  
 Tobacco use is one of the most significant health issues that the U.S. military 
faces today. In 2002, it was estimated that among military members, 33.8% were 
smokers, with the Marines holding the highest rate (38.7%) and the Air Force the 
lowest (27.0%) (Pyle et al., 2007).  Smoking is responsible for a wide range of health 
problems, such as injuries, poor performance on fitness tests, and increased days of 
sickness (Pyle et al., 2007). In addition, tobacco use, apart from the harmful health 
effects that causes, is a serious financial burden for the U.S. The cost effects of 
smoking in the U.S. military result in high healthcare expenses, productivity loss, lost 
work days because of absenteeism and early discharge of active duty personnel-- 
something that is more often observed in the Air Force. Air Force recruits who 
smoked, compared to non-smokers, were more likely to be discharged prematurely, 
burdening the DoD budget with an annual cost of $130 million, exceeding training 
expenditures (Klesges et al., 2001).  
 Additionally, there is concern due to the increased use of smokeless tobacco 
among military recruits and military members (Severson et al., 2009).  The personnel 
of the U.S. military represent a remarkable percentage of the total population using 
smokeless tobacco. The use of smokeless tobacco is increasing among military 
personnel and its prevalence is found to be approximately twice, compared to the 
general population (Severson et al., 2009).  Smokeless tobacco is mistakenly believed 
to be a safer alternative to smoking tobacco and that i s use does not influence human 
health as much as smoking tobacco.  However, smokeless tobacco has been found to 
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be more addictive than smoking tobacco and its users are more likely to become 
smokers than non smokeless tobacco users (Ebbert et al., 2006).  
 Few studies have investigated the reasons that cause smoking initiation among 
those who have never smoked, recividism among former s okers, or increased 
smoking frequency among current smokers.  Some studie  provide evidence that 
deployment of military personnel in battlefields is an important factor that affects both 
smoking initiation and relapse among non-smokers and former smokers, and 
additionally increases the tobacco consumption among current smokers (Poston et al., 
2008).  The deployment of active military personnel to active combat zones has 
increased over the last 20 years, since the U.S. partici tion in the Gulf War. It has 
been noted that there might be a relationship between the deployment and increased 
tobacco consumption among current smokers, initiation of smoking among never 
smokers or relapse among former smokers (Poston et al., 2008).  The reasons most 
commonly quoted for smoking initiation or increased tobacco use during deployment 
are boredom, operational stress and anxiety. In addition, the lack or the limited 
availability of alternative activities such as gyms and movie theaters in an operational 
environment could increase tobacco consumption. Moreover, the misconception that 
the dangers that smoking causes are minimal, in comparison to the risks the deployed 
personnel face in the battlefield and the military environment of an operational theater 
may encourage tobacco use or increase the overall attitude of lenience toward 
smoking (Poston et al., 2008).  
 Military smoking is an increasingly important issue, because tobacco use 
negatively affects troop readiness and productivity, and in addition increases medical 
and training costs (Arvey and Malone, 2008). Given these effects, banning smoking 
within the military would be considered by many to be both militarily and fiscally 
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prudent. In 1985, the DoD conducted research on military smoking issues and found 
that tobacco use rates among military members were significantly higher than U.S. 
civilian rates and, additionally, it concluded that smoking affects readiness and 
estimated the cost effects of smoking related to healt care (Arvey and Malone, 2008). 
On March 10, 1986, DoD announced an intense anti-smoking campaign through 
directive 1010.10 (Arvey and Malone, 2008). Directive 1010.10 was not just a mere 
educational program on quitting smoking, but went fur her than that, setting 
restrictions and specifying where individuals could smoke on military installations 
and when smoking would be permitted (Arvey and Malone, 2008). Directive 1010.10 
also tried to educate and inform military members about the risks of tobacco use and 
tried to prevent personnel from initiating smoking, and to help personnel quit. 
Practitioners were educated, during the routine healt  xaminations, to advise people 
about the risks related to smoking, the health benefits of abstinence and where they 
could get help to quit smoking (Arvey et al., 2008). Smoking prohibitions in indoor 
facilities were made more specific by Directive 1010.15, an extension of Directive 
1010.10. Despite this extension, tobacco control policy has made small steps and has 
changed little since 1986 (Arvey et al., 2008).  
In conjunction with the policy change, cessation assistance is offered to active 
duty military members. The program incorporates education techniques and nicotine 
replacement therapy, such as nicotine patches and nicotine gum, to assist in quitting 
the harmful smoking habit. The anti-tobacco policy tries to discourage individuals 
turning to alternative methods of tobacco use such a ewing or smokeless tobacco. 
This policy is amplified by the prescription and use of specific drugs that help kicking 
the habit of smoking, such as Chantix and Zyban (Commander, Submarine Forces 
Public Affairs, 2010).  
8 
 Tobacco smoking deserves special consideration, since it affects the health, 
the quality and the readiness of the military personnel. In this way, tobacco smoking 
merits increased deliberation as an accessional benchmark of the quality of the 
military personnel, for various reasons. One of them is that the DoD suffers a serious 
financial burden from tobacco use. In 1998, DoD healt c re costs were estimated to 
have been inflated by $584 million annually, and in the same year, it was estimated 
that smoking created an additional cost of $346 million because of the annual cost of 
lost productivity (Larson et al., 2007). Moreover, smoking negatively affects the basic 
military training of recruits. Studies in the Navy found that smoking was one of the 
factors that predicted attrition in the first year of service and that 1,500 more recruits 
would graduate the after the 15-month period of training, if only non-smokers were 
recruited (Larson et al., 2007). The same findings are consistent with studies and 
researches on tobacco use in the Air Force. Smoking was one of the strongest 
predictors for discharge from training, compared to other predictors like 
demographics, education or even alcohol or drug use. In addition, estimates proved 
that recruits who smoke are related to an additional e cumbrance of $18 million for 
the Air Force budget per year, because of excess training costs (Larson et al., 2007). It 
should be noted that smokers tend to have higher rat s of absenteeism and are more 
often subject to injuries, compared to non-smokers. This fact has implications for 
organizational costs and productivity and consists of an additional predictor for the 
educational credentials and mental ability of the military personnel (Larson et al., 
2007). In conclusion, smoking status could be considered as a predicative personnel 
quality benchmark. 
 Despite the fact that tobacco cessation measures and policies are a significant 
component of military health promotion programs, approximately one third of the 
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DoD personnel use tobacco, which is a percentage very close to the smoking rate 
among U.S. civilians and creates doubts about the physical and mental quality of the 
Army Forces (Larson et al., 2007).  In addition, the U.S. military has always acted as 
a role model for society. Recent studies show that military members see themselves as 
role models for the rest of the society and in thisway, a smoke-free and healthy 
military could be the benchmark of pride and consistency (Hoffman et al., 2008). 
Career military members and the military personnel stationed in supervisory roles 
should provide appropriate and healthy models. Moreover, they should render 
themselves responsible for the transmission and dissemination of an influential 
message in changing the conception and admittance of tobacco use by military 
members (Nelson and Pederson, 2008).  
It is apparent that the issue of smoking has been th  subject of ample research, 
therefore, considerable literature on the issue exists both in terms of the general 
population overall as well as the more specific issue  of the United States and the U.S. 
military. Studies have shown that recently, the rats of smoking among the general 
population of the United Studies have decreased, while other studies have 
documented a high predominance of smoking among the military personnel, before 
and after their admission  into the military (Nelson and Pederson, 2008). Smoking is 
more intense among deployed military members, because of stress, boredom, family 
separation and lack of other alternatives of entertainment. The military has adopted a 
subset of tobacco related objectives, which include the reduction of smoking and the 
elimination of the use of smokeless tobacco. The tobacco cessation programs are 
focusing on reducing the acute and alarming issue of sm king among the military 
members.  
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This study focuses on examining and analyzing the smoking rates among the 
active duty members of the Air Force of the United States. Smoking is a severe 
phenomenon for the Air Force today because it is negatively associated with 
readiness, fitness level and health quality of the personnel. Tobacco use in the Air 
Force is connected to premature death from diseases related to smoking, economic 
losses to society and a remarkable burden on the healthcare governmental budget.  
Huge healthcare expenditures and yearly lost productivity are the results of the high 
rates of smoking among the Active Duty of Air Force (ADAF). Moreover, this study 
tries to classify the most prevalent diseases related to smoking, according to their total 
cost, for which ADAF members have been conveyed to hospital. Smoking and high 
medical care costs are intimately connected, creating  huge burden on the healthcare 
budget of the DoD. In addition, this study makes an effort to detect any potential 
relationship between the cost of hospitalization of ADAF personnel because of 
smoking related diseases and various predictors related to socio-demographic 
characteristics of the population of ADAF.   
The rates of smoking among the ADAF can be classified according to age, 
gender and rank. Tobacco use is more popular and widespread among the younger 
ADAF and especially among the enlisted ranks. Factors such as gender, age group and 
pay rank, affect the intensity of smoking, the health standard of the U.S. Air Force 
personnel and the magnitude of the relevant economic losses.  
The first part of this study is based upon data extracted from the Air Force 
Web Health Assessment (AF Web HA) questionnaire, more specifically from the 
section of AF Web HA which refers to demographics and questions associated to 
smoking and tobacco use. Web HA is an online questionnaire completed by military 
members as part of annual medical assessments.  The demographics give substantial 
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information about the profile of the interviewee which include gender, age and pay 
rank. The Tobacco-Use section of AF Web HA gives information about current 
smoking status of Air Force personnel and this section is used in this research for 
measuring the smoking trends among the ADAF members and their association with 
specific socio-demographic characteristics. The Tobacco-Use section of AF Web Ha 
questionnaire is given in Appendix A (AF Web HA, 2010).  
 The second and third part of this study is based on ata obtained from the Air 
Force Medical Support Agency’s Healthcare Informatics Division (AFMSA/SG6H). 
This dataset includes cost data of direct and network care, provided to ADAF 
personnel, because of smoking related diseases. The information extracted from this 
dataset is used for two purposes:  
• For rating the most prevalent diseases related to smoking, according to 
their total cost, and providing additional information associated with the 
socio-demographic characteristics of the population 
• For trying to detect any potential relationship between the cost of 
hospitalization and various variables affecting this cost  
The purpose of this study is to analyze statistically the data obtained from the 
AF Web HA records, present the current smoking statu  of Air Force, and make a 
resource about who smokes more according to gender, ag  and pay rank. 
Additionally, this study focuses on the most prevalnt diseases that are associated 
with smoking, and analyses them on a cost basis, in order to sort them out according 
to their cost and track any relationship between this cost and any characteristics 
referred to the ADAF members.  
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Research Objectives 
 Research Questions 
1) How is smoking affected by the socio-demographic characteristics of the 
ADAF population? 
• How is smoking affected by pay rank? 
• How is smoking affected by gender? 
• How is smoking affected by age? 
2) Which diseases cost most to the U.S. Air Force, according to their total 
cost of hospitalization?  
3) How is the cost of hospitalization affected by gendr, age, pay rank and 
each disease separately?  
Research Focus  
 The initial area of research focuses on determining a d measuring smoking 
rates in the U.S. Air Force, specifically the active duty members. The measurement of 
these rates is based on data, extracted from the AF Web HA questionnaire data, which 
gives important information about the tobacco use in Air Force, sorted by gender, age 
and pay rank. The secondary area of the research is exploring the hierarchy of the 
most prevalent diseases related to smoking, according to their cost and providing 
some information about the cost of these diseases, relating it to more specific 
characteristics associated with the population of ADAF. The third area of the research 
is based on the detection of any predictability of the cost by variables related to socio-
demographic characteristics of the ADAF personnel.  
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Assumptions 
 The data sets used in this research demand the establishment of some 
assumptions, which allow better manipulation of them to make them useable for this 
analysis. Starting with the first data set of AF Web HA, rows with blank cells 
referring to age, gender and pay rank were assumed to be erroneous and were deleted. 
Moreover, there were some rows referring to the rank of Warrant Officer. Since this 
pay rank no longer exists in the Air Force, and the rows referring to this pay rank 
were very few, they were deleted. These actions were taken for a better manipulation 
of the data set and for the elicitation of undistorted results.  
 The second data set, including the cost of hospitaliza ion of ADAF because of 
diseases related to smoking, was reformulated, as below:  
• The columns Diagnosis 2 up to Diagnosis 9 (Secondary Diagnoses) were 
excluded from the data set.  Only the Diagnosis 1 column, which includes the 
ICD-9 coding of the Primary Diagnosis, was kept for this research.  
•   The Primary Diagnosis, and subsequently the whole data set, was restricted 
to the ICD-9 codes which refer to the most prevalent smoking related diseases, 
according to Smoking Attributable Mortality, Morbidity and Economic Costs 
(SAMMEC, 2010). The most prevalent diseases related to smoking and their 
ICD-9 codes, according to SAMMEC, are given below in Table 1.  
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Table 1. Most Prevalent Diseases Related to Smoking (SAMMEC, 2010) 
Disease Category ICD 9 Codes 
MALIGNANT NEOPLASMS  
Lip, Oral Cavity, Pharyx 140-149 
Esophagus 150 
Stomach 151 
Pancreas 157 
Laryx 161 
Trachea, Lung, Bronchus 162 
Cervix Uteri 180 
Kidney and Renal Pelvis 189 
Urinary Bladder 188 
Acute Myeloid 205 
CARDIOVASCULAR DISEASES  
Ischemic Heart Disease 410-414, 429.2 
Other Heart Disease 390-398, 415-417, 420-429.1, 429.3-
429.9 
Cerebrovascular Disease  430-438 
Atherosclerosis  440 
Aortic Aneurysm  441 
Other Arterial Disease  442-448 
RESPIRATORY DISEASES  
Pneumonia, Influenza 480-487 
Bronchitis, Emphysema  490-492 
Chronic Airway Obstruction 496 
 
• There were two rows with the index unisex (U) for gender. Those were 
deleted. 
• There were three rows with the index Air Force (AF), ten rows with 
the indices Warrant 1, Warrant 2, Warrant 3 (W1, W2, 3) and 2 rows 
with the index XX for pay rank. Those were deleted.  
• There were 2 rows with the index zero and nine for age. Those were 
deleted, also. 
• The cost was expressed in ThenYear Dollars. The use of cost data, 
which incorporates time value of money associated with inflation, 
demands its conversion to Constant Year Dollars. The procedure and 
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method of this conversion is presented and described in a detailed way 
in Chapter III.  
The above described assumptions were made for a better management of the 
data sets and for the exclusion of some erroneous inputs that would distort the 
analyses and the results of this study. Furthermore, the restriction of the field of the 
research to the most prevalent diseases related to smoking according to SAMMEC 
enables the researcher to focus on those diseases that provoke the majority of the 
health problems related to smoking and investigate their influence on cost. It is 
acknowledged here that ICD codes are judgment calls of the medical provider and 
can, in theory, be incorrect.  However, for this reearch, it is assumed that these are 
accurate diagnoses.  Also note that it is assumed for this research that smoking is the 
primary cause of the diagnoses.  
 
Preview 
 The discussion will begin with a review of the existing literature on smoking 
worldwide, in the United States, the Department of De ense and the Air Force. In 
Chapter III, the methodology used in this study will be presented, explaining which 
methods and what kind of analyses were used in each case. In Chapter IV, a 
Contingency Analysis will be developed to determine th  rates of smoking among 
ADAF. Subsequently, a Pivot Table Analysis will be d veloped and will be 
graphically presented the cost rating of the most prevalent diseases related to 
smoking. The next step will be the development and presentation of a Regression 
Analysis for the exploration of potential statistical relationship between cost and 
various variables regarding the population examined  this study. Finally, the 
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conclusions of the research will be discussed, along with the efficacy of the cessation 
policy and what additional measures could be taken in the framework of the 
promotion of quitting smoking.  
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II.  Literature Review 
 
Tobacco Use and its Health and Cost Effects Around the World 
 Numerous studies have been done all around the world focusing on smoking 
and the harmful effects on human health and, consequently, on society. The World 
Health Organization (WHO) has been dedicated to the fig t against smoking for many 
years and has conducted many studies on the detrimen al consequences of the tobacco 
use. Every year WHO organizes campaigns against smoking in numerous countries, 
trying to inform people of the adverse health effects of smoking while launching 
programs for the cessation of tobacco use. In 2008, WHO published the “WHO 
Report on the Global Tobacco Epidemic, 2008: the MPOWER Package.” This report 
refers to the smoking problem as a devastating epidemic that threatens the lives of one 
billion men, women and children during the 21st century:  “Prompt action is crucial. 
The tobacco epidemic already kills 5.4 million peopl  er year from lung cancer, heart 
disease and other illnesses. Unchecked, that number will increase to more than 8 
million a year by 2030” (WHO, 2008). 
Tobacco use is spread throughout the world because of successful direct and 
indirect marketing, low prices, lack of awareness of its effects on health and the 
economy, and ineffective policies against smoking. While the tobacco epidemic might 
be destructive, it is preventable and it can be significantly decreased if prompt action 
is taken. The WHO has established the MPOWER, a setof six significant measures 
against smoking: 1) raise taxes on tobacco products, 2) ban of marketing, sponsorship 
and advertisements of tobacco products, 3) the protecti n of non-smokers and people 
that suffer from second-hand smoking, 4) better information and awareness about the 
harmful effects and dangers of smoking, 5) offer of help to those who want to try and 
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quit smoking and 6) effective monitoring of the tobacco use epidemic and of the 
application of cessation policies.  
The WHO report emphasizes that there still are crucial issues to be resolved, 
in order that further steps can be taken towards the extinction of the smoking problem. 
Among these issues are: 1) the weak monitoring and the lack of data on tobacco 
related diseases and deaths, which would propel effective tobacco control,  2) the 
inadequate implementation of smoke-free laws (only 5% of the global population is 
protected by these laws according to the WHO report), 3) insufficient establishment of 
cessation programs, 4) the unawareness of the full xtent of health risks smoking 
induces in the majority of smokers, 5) the economic power of tobacco industries and 
the ineffective enforcement of bans on tobacco advertising, promotion and 
sponsorship and 6) the relevant low prices of tobacco products and their low taxation.  
WHO and the MPOWER set of policies focus on these is ues, in order to fight 
against the tobacco epidemic. Moreover, this report emphasizes the power of the 
tobacco industries and their dynamic marketing of their products. According to the 
WHO, the tobacco industry as a whole is a disease vector and spreads its epidemic 
through direct and indirect promotion in every angle of the planet.  
The developed countries are already experiencing the harmful health and 
economic effects of smoking and now on the list are low-income and poor countries 
without any tobacco control or effective policies against tobacco use. Poverty is one 
of the long-term net economic effects of smoking. The tobacco industry’s objective is 
to attract more users and to convert them into addicte  smokers and this addiction 
disproportionately hurts the poor. After striking the wealthy and developed countries, 
smoking strikes poor countries now, augmenting the gap between wealthy and poor 
countries, since a smoker in a poor country in order to purchase tobacco, deprives 
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himself and his family from basic necessities such as food, shelter, education, and 
healthcare. In addition, the tobacco industry targets women and adolescents, trying to 
expand its clientele and create more addicted users. The tobacco industry is well-
funded and more politically powerful and its strength can be restricted only through 
severe unbiased political action.   
 Young people and adolescents are also targeted by sophisticated and 
misleading advertising campaigns and tobacco industries spend millions on 
advertisements, trying to create more smokers, presenting smoking as a kind of 
emancipation, glamour and independence (Mackay and Eriksen, 2002). The foreword 
of Dr. Gro Harlem Brundtland concludes stating the aim of the Tobacco Atlas and the 
Tobacco Free Initiative, which is the enhancement of the global awareness of tobacco 
consumption and its effects in every aspect of  human life, and the construction of 
new and the strengthening of  existing actions against the devastating phenomenon of 
smoking.  
 This literature review will focus on several trends, beginning with male 
smoking, where worldwide almost one billion males smoke.  This includes 35 percent 
in developed countries and 50 percent in developing countries (Mackay and Eriksen, 
2002). Moreover, the smoking rates among men have peaked but they are declining at 
a slow tempo (Mackay and Eriksen, 2002). Educated mn tend to give up smoking 
more than uneducated men. This fact implies that smoking is transforming into a habit 
of the low-education and the low-financial status men (Mackay and Eriksen, 2002).  
The current number of female tobacco users is estimated at 250 million 
worldwide. This rate is analyzed in more detail, consisting of 22 percent of female 
smokers in developed countries and 9 percent of female smokers in developing 
countries (Mackay and Eriksen, 2002). The tobacco industries, in an effort to gain 
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more female “clients” and expand their market share, p omote special advertising 
campaigns using misleading icons of emancipation and allurement. In addition, they 
launch special tobacco products for women, the so called “feminized cigarettes”, 
trying to create more female smokers (Mackay and Eriksen, 2002).  
The Atlas makes a reference to youth smoking, mentioning that the majority of 
smokers begin using tobacco before reaching adulthood. The factors that contribute to 
the rise of smoking rates among adolescents are the specialized tobacco industry 
advertising, the relatively low prices of tobacco pr ducts and easy access to them. 
Starting the harmful habit of smoking during adolescence, makes teenage smokers 
even more addicted to it, and expands the danger of contracting smoking related 
diseases, such as heart disease and lung cancer, in their 30s or 40s (Mackay and 
Eriksen, 2002).  
 It is very noticeable that, while the consumption presents an image of 
stabilization or even decreasing in some countries, worldwide, the number of people 
smoking increases, especially because of the expansion of the world’s population.  
Those who smoke prefer mainly cigarettes. Ninety six percent of tobacco 
product sales are from cigarettes (Mackay and Eriksen, 2002). The Atlas gives a short 
list of the regions of the planet that consume the biggest share of cigarette production 
worldwide. Tobacco sales and consumption are greatest in: “Asia, Australia and the 
Far East (2,715 billion cigarettes), followed by the Americas (745 billion), Eastern 
Europe and Former Soviet Economies (631 billion) and Western Europe (606 
billion)” (Mackay and Eriksen, 2002).  
The Tobacco Atlas focuses on the cost of smoking to the economy and to the 
smoker. Commencing with the cost to the economy, the tobacco companies claim that 
smoking and subsequently the production of tobacco products benefits the economy 
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and if all the tobacco control measures were to go into action, then tax revenues 
would decrease dramatically (Mackay and Eriksen, 2002). Many people that work in 
the tobacco industry would be unemployed and the economy would be called to face a 
serious hardship. But the tobacco companies avoid mentioning the economic losses 
that economy suffers from smoking. Tobacco use creates great losses to governmental 
economies, to the employers and to the environment b cause of the healthcare 
expenses due to smoking related diseases, absenteeism, d creased productivity, loss of 
foreign exchange because of the import of tobacco products, accidents, and 
deforestation because of careless fires caused by smoking or loss of land that could be 
used to cultivate food instead of tobacco.  
Regarding the cost to the smoker, the main cost is the money spent on tobacco 
and cigarettes, which diverts money away from buying food, clothing or shelter. 
Moreover, a smoker may experience the loss of income because of illness and the loss 
of family income because of the time taken by the family members to look after a 
smoker. Smokers often have to deal with higher healt c re or insurance expenses, 
facts that dramatically decrease their net income.  
 Education is the most substantial part of the process of tobacco control. All the 
anti-smoking measures or any taxation and legislative intervention would not be 
meaningful without the understanding of their effectiveness. The purpose of the anti-
smoking education is  to focus not only on the harmful effects of smoking, but also 
aims to teach people, especially young people, how t ey could refuse this harmful 
habit.  The Tobacco Atlas cites the efforts of quitting smoking and which techniques 
can be successfully utilized to quit the use of tobacco. The most popular techniques 
are: “Social support, clinics, quitlines, internet sites, skills training, nicotine 
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replacement therapy (NRT), and other pharmaceutical tre tments” (Mackay and 
Eriksen, 2002).  
The last part of the Tobacco Atlas makes some prognostics about the future of 
the tobacco epidemic. The most prevalent prediction is that the tobacco epidemic is 
increasing and expanding, while shifting from develop d countries to the developing 
ones.  Moreover, it is predicted that more women will be smoking in the future 
(Mackay and Eriksen, 2002). The remiss legislative int rventions and the lack of 
structured and scientific information about the harmful effects of smoking, and the 
role of the powerful tobacco industries in the developing countries reinforce the 
expansion of the epidemic. The Tobacco Atlas describes the future as “bleak” unless 
immediate and considerable action is taken now. Studies, research reports and the 
several anti-smoking policies have proven that smoking rates can be significantly 
decreased if every government and nation takes sustained and decisive measures 
against the epidemic. (Mackay and Eriksen, 2002)       
Smoking and its Effects in the United States       
Tobacco use in the United States, along with exposure to tobacco smoke, are 
two of the most preventable causes of premature deaths due to chronic diseases, 
negative financial effects to society, and an economic impairment of the country’s 
healthcare system. It has been estimated that at least 30% of all cancer related deaths, 
almost 80% of the deaths associated with chronic obstructive pulmonary disease and 
early cardiovascular disease and deaths related to it, are primarily engendered by the 
harmful habit of smoking (Adhikari et al., 2008). In order to assess the extent of the 
economic loses and the magnitude of the burden on the healthcare system of the 
United States because of smoking, the same team of Adhikari et al., conducted a 
study, which was an analysis of SAM (Smoking-Attributable Mortality) and of YPLL 
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(Years of Potential Life Lost) because of smoking, based on data of the Centers for 
Disease Control’s (CDC) SAMMEC (Attributable Mortali y, Morbidity, and 
Economic Costs) system. The analysis focuses on the years 2000-2004 and indicates 
that during this period the use of cigarettes and the exposure to cigarette smoke was 
responsible for at least 443,000 premature deaths, pproximately 5.1 million YPLL 
and $96.8 billion in productivity losses annually in the United States (Adhikari et al., 
2008).  
The same analysis uses the sex and the age of the smokers and people exposed 
to tobacco smoke as leading variables, and is focused on nineteen adult and four 
infant disease categories. According to this analysis, during the period of 2000-2004, 
the estimated annual averages of deaths provoked by smoking were 269,655 deaths 
among males and 173,940 deaths among females in the United States (Adhikari et al., 
2008).  
It is worth mentioning that, among the nineteen adult iseases, the most 
prevalent diseases attributable to smoking were lung cancer, ischemic heart disease 
and COPD (Chronic Obstructive Pulmonary Disease). Prcentages of deaths among 
adults 35 years or older, indicate that 41% of smoking associated deaths were 
engendered by cancer, 32.7 % by cardiovascular disease  and 26.3% by respiratory 
diseases. Along with the adult deaths, it was estimated that 776 infants died annually 
due to smoking during pregnancy, and 49,400 cases of lung cancer and heart disease 
annually were related to second-hand smoking (Adhikari et al., 2008).  
Citing the economic effects of smoking, the same analysis mentions that for 
the same period of 2000-2004, the average productivity loss assignable to smoking 
was $96.8 billion, where $64.2 billion was attributed to males and $32.6 billion to 
females (Adhikari et al., 2008).  Even though the smoking rates have declined 
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significantly compared to 1960s when they had reachd t eir peak, the number of 
deaths attributed to diseases related to smoking is almost the same, because 
population has increased. This increase of the population contributes to the increase of 
the absolute number of deaths, even though the rates of smoking attributable diseases 
have relatively decreased (Adhikari et al., 2008).  
During the period of 2000-2004, the total economic burden of smoking was 
$193 billion per year, including healthcare expenditures (which had been calculated to 
be almost $96 billion) and productivity losses (approximate estimation was $97 
billion).  This burden is 325 times larger than $595 million, which was the total cost 
of investments in tobacco control and cessation programs in fiscal year 2007 
(Adhikari et al., 2008). Tobacco control and cessation programs could expedite the 
decline in smoking rates and subsequently the reduction in expenditures related to 
productivity losses and healthcare expenditures related to smoking.     
 Morbidity and Mortality Weekly Report (MMWR) published an article in 
September 2010 regarding the national and state adult smoking prevalence, reporting 
that even though the prevalence of smoking has declined the past 30 years in the 
United States, it continues to be the leading cause of cardiovascular diseases, multiple 
cancers and pulmonary diseases. Combined, these diseases cause the death of 
approximately 443,000 people annually and encumber the governmental budget with 
$ 193 billion annually, including healthcare expenditures and productivity losses. 
Even though the smoking rates have decreased over the past 30 years, the 
phenomenon of smoking is still one of the most alarming and widespread in the 
country (Dube et al., 2010).  The report is based on 2009 data from the National 
Health Interview Survey. According to this data set, in 2009, 20.6% (46.6 million) of 
the adults of the United States were current smokers. Of these 46.6 million smokers, 
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36.4 million (78.1%) were regular smokers smoking o daily basis, and 10.2 million 
(21.9%) smoked on some days. In addition, smoking was more prevalent among men 
(23.5%) than women (17.9%) (Dube et al., 2010).  Referencing racial groups, 
smoking was less prevalent among Asians (12.0%) and Hispanics (14.5%), compared 
to non-Hispanic Blacks (21.3%) and non-Hispanic Whites (22.1%). Smoking was 
most prevalent among multiple races (29.5%) and American Indians/Alaska Natives 
(23.2%) (Dube et al., 2010).  Counting the smoking prevalence according to regions, 
the Midwest stands for the highest prevalence (23.1%) followed by the South 
(21.8%), and the West with the lowest prevalence (16.4%) (Dube et al., 2010). 
Smoking prevalence varies when it is observed by education level. Smoking rates 
were higher in 2009 among adults with a General Educational Development 
certificate (GED) (49.1%), and they tended to decline as the education level increased, 
reaching their lowest value (5.6%) among those witha graduate level degree. It is 
remarkable that smoking prevalence was higher among people living below the 
federal poverty level (31.1%), compared to those living at or above this level (19.4%) 
(Dube et al., 2010).  The MMWR article concludes with the importance of tobacco 
control and cessation programs, referring especially to the states with the lowest 
smoking prevalence (Utah and California) and how successful and effective their 
long-running tobacco control programs have been (Dube et al., 2010).  The article 
emphasizes the importance of anti-smoking strategies, such as price increases on 
tobacco products, concise smoke-free policies, and well organized campaigns and 
their implementation combined with access to efficient treatments and services.  
 Centers for Disease Control and Prevention (CDC) website provides valuable 
and important information about the smoking trends i  the U.S., which correlate with 
the information previously given in the article from MMWR. The page is called Fast 
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Facts, last updated in September 2010 and last review d in October 2010, and besides 
the smoking rates of the U.S. in 2009, provides additional financial information, 
concerning the money spent in the advertising and promotions by the tobacco 
industry, the amounts available for tobacco control p grams and the cost of second-
hand smoking. The percentages of adults in the United States that were current 
smokers in 2009, are given in Table 1 (CDC, 2010):   
 
Table 2. Percentages of U.S. Adults Current Smokers in 2009 (CDC, 2010) 
Category Percentage 
All U.S. Adults  20.6 %  
American Indian/Alaska Native Adults 23.2 %  
White Adults 22.1% 
African American Adults 21.3%  
Hispanic Adults 14.5% 
Asian American Adults 12.0%  
 
 An adult is defined as a person 18 years or older and a current smoker is 
considered a person who has reported that he/she ha smoked at least 100 cigarettes 
during their lifetime and at the time of interview declared that they smoked every day 
or some days. Each day, approximately 1,000 persons under the age of 18 years old 
begin the harmful habit of smoking while every day 1,800 adults of 18 years old or 
older, begin tobacco use on a daily basis (CDC, 2010). CDC states that smoking costs 
almost $193 billion annually, an amount that consists of $97 billion lost in 
productivity and $96 billion in healthcare. A remark ble piece of information is that 
second-hand smoking costs more than $10 billion annu lly, a cost which is composed 
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of healthcare expenditures, morbidity and mortality (CDC, 2010). The same web page 
provides additional information about the funds spent for tobacco control and 
cessation programs. According to this report, in 2008, $24.4 billion was available to 
states, funds concentrated by excise taxes and legal s ttlements, for tobacco control 
programs, but only a small percentage (<3%) was spent for this purpose (CDC, 2010).  
Moreover, enormous amounts of money were spent by the tobacco industry, in order 
to reach its promotion aims. In 2006, $12.5 billion was spent totally for advertising 
campaigns (CDC, 2010). 
 MMWR, in an older article, makes a distinction betw en smoking morbidity 
and smoking mortality. The article talks about the cigarette smoking attributable 
morbidity in the United States in 2000 and there is a reference that labels the 
difference between morbidity and mortality. Data rel t d to mortality indicate the 
number of individuals that die each year because of a disease attributed to smoking, 
while morbidity data is associated with the prevalence of persons that bear a disease 
affiliated to smoking (MMWR, 2003). The article focuses on the diseases attributable 
to smoking morbidity and mentions that in the United States, in 2000, approximately 
8.6 million people had serious diseases related to sm king and chronic bronchitis and 
emphysema, which are accountable for a percentage of 59% of all smoking 
attributable diseases (MMWR, 2003). More specifically the article mentions: 
In 2000, an estimated 8.6 million (95% CI=6.9-10.5 million) persons in the 
United States had an estimated12.7 million (95% CI=10.8-15.0 million) 
smoking-attributable conditions. For current smokers, chronic bronchitis was 
the most prevalent (49%) condition, followed by emphysema (24%). For 
former smokers, the three most prevalent conditions were chronic bronchitis 
(26%), emphysema (24%), and previous heart attack (24%). Lung cancer 
accounted for 1% of all cigarette smoking-attributale illnesses. (MMWR, 
2003) 
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Tobacco Use in the United States Military and Air Force  
 There is not vast literature on the topic of tobacco use in the U.S. Air Force. 
The majority of the articles and the studies focus on the association between smoking 
and the enlisted ranks of the Air Force, the use of smokeless tobacco and smoking 
during deployment. A common theme of these studies is the necessity of the 
implementation of a more active control and cessation smoking policy.  
A study on active duty members of the U.S. Air Force, published in 2000, 
provides costs of smoking for active duty personnel of the Air Force for the year 
1997. The article mentions that almost 25% of male and 27% of female active duty 
personnel aged between 17 and 64 years were smokers in 1997 (MMWR, 2000). 
Moreover, the estimated costs of current smoking, according to a study conducted in 
1997 for the ADAF members, reached approximately the amount of $107.2 million 
per year, which was composed of $20 million for medical care expenses and $87 
million for lost workdays (MMWR, 2000). The $20 million of healthcare expenses 
represent 6% of the total budget of the Air Force delegated to medical care 
expenditures and the $87 million of lost workdays was comprised of $76 million for 
lost workdays among males and $11 million among femal s (MMWR, 2000). The 
DoD estimated that in 1995, $584 million was spent annually in the healthcare sector 
because of smoking attributable diseases and $346 million of lost productivity 
occurred.  
 A similar study, presenting and analyzing the costs f mortality and morbidity 
attributed to smoking within the DoD, was conducted by Helyer et al. and published 
in 1998, using data from the year 1995 and the methodology of the Centers for 
Disease Control and Prevention. The population was comprised of active duty 
members of DoD, their families, retirees, and their d pendents aged under 69 years 
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old. The study mentions that in 1995, the prevalence of smoking among the active 
duty personnel of the DoD was 31.6%. 54.6% of active duty members were never 
smokers, while 13.8% were former smokers (Helyer et al., 1998).  The study makes a 
distinction between direct and indirect costs. The dir ct costs include direct healthcare 
costs, productivity loses and premature deaths. The total direct healthcare costs 
counted for $584 million, the largest amount was attributed to hospitalization costs, 
77%, while 18% was ascribed to physicians’ fees (Helyer et al., 1998).  Male smokers 
were responsible for the largest share of the direct h althcare costs, 74%, and the 
majority of them belonged to age group 35 to 64 years (Helyer et al., 1998). The study 
rates smoking related diseases according to their sare of responsibility in provoking a 
premature death. The cardiovascular diseases were responsible for 45% of the 
premature deaths attributable to smoking, neoplasms and lung cancer accounted for 
35% of deaths and respiratory diseases were found at the third place of this 
assortment, with the percentage of 19% (Halyer et al., 1998). The premature deaths 
associated with smoking accounted for 16% of the deaths in the population of the 
DoD, almost one in six deaths (Halyer et al., 1998). In 1995, active duty members 
were hospitalized for 9,239 days because of a smoking related disease, and the cost 
connected with those days was almost $1 million. The cost of smoke breaks totaled 
$345,199,197 (Halyer et al., 1998). Enlisted personnel accounted for the 32.6 % of the 
current smokers, while among the officers ranks, 9.5% of smokers was accounted to 
the pay ranks O1-O3 and 7.1% to the pay ranks O4-O10 (Halyer et al., 1998).  
 One of the major concerns of the DoD in recent years is the unhealthy lifestyle 
of the military population and its dependents, and its consequences, financial and 
social, on the DoD itself. Tobacco use, overweight and obesity, and high alcohol 
consumption (referred as “TOBESAHOL”) are the principal unhealthy behaviors of 
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the active members of the U.S. military, which adversely affect the quality of their 
health level, because of the numerous diseases caused by TOBESAHOL, and create 
costs of billions of dollars because of medical care expenses, lost productivity and 
premature decay (The Lewin Group, 2010). The Office of the Assistant of Defense, 
using the “Military Health System (MHS) Cost of Disease Estimator (CoDE), and 
based on a User-defined scenario that includes the TRICARE Prime beneficiary Air 
Force population stationed in CONUS,” conducted a repo t that estimates the rates 
and costs of TOBESAHOL among active duty members of the Air Force and their 
dependents, and the Air Force retirees aged under 65 years old and their dependants, 
for Fiscal Year 2008. Of the $774 million of DoD medical costs due to TOBESAHOL 
in 2008, $174 million were attributed to problems generated by smoking (The Lewin 
Group, 2010). The tobacco use in this study was defined as the use of cigarettes and 
smokeless tobacco. Referring to the smoking rates among the active duty personnel of 
the report, an approximate number of 392,000 TRICARE Prime adult enrollees, 
expressed in a percentage of 46% of total TRICARE PIME adult enrollees, were 
current smokers, and men were more likely than women to be moderate to heavy 
smokers. Correspondingly, young adults were more susceptible to be current smokers 
than older adults (The Lewin Group, 2010).  
 Some years ago a survey was conducted, based on every trainee entering the 
USAF enlisted force from August 1995 to August 1996 in order to provide 
information on the factors affecting trainees that urge them to smoke. The sample of 
the survey consisted of 32,144 trainees entering the enlisted ranks of the USAF for the 
period August 1995 – August 1996 and the data were coll cted on the basis of four 
general domains: demographic data, the background of sm king, coefficients related 
to tobacco use, and other risk factors. The results howed that the trainees that were 
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married, those that came from families with high income, those with low education 
level and Euro-Americans were more susceptible to sm ke (Haddock et al, 1998). The 
survey demonstrated that one of the most forceful predictors of the smoking status of 
the trainees, participating in the survey was their concept of the social attractiveness 
of smoking (Haddock et al, 1998). 
In their research, Klesges et al. showed that 28.5% of the 29,044 recruits who 
entered the Basing Military Training (BMT) of the Air Force from August 1995 to 
August 1996 were smokers.  Smokers were 1.8% more likely to be discharged from 
the BMT during the first year, compared to non-smokers. Among the Air Force 
recruits, of the 14% discharged, 19.4% were smokers and 11.8% non-smokers 
(Klesges et al., 2001). The associated excess training costs of discharged recruits 
reached the amount of $18 million per year for the Air Force and assuming that, the 
same ratio of recruits prematurely dismissed because of moking was applied to other 
services of U.S. military, the total military annual excess costs of training would 
approximately account for $130 million (Klesges et al., 2001). In addition, the 
investigation mentions that smoking status, compared to the rest of the demographic 
predictive variables used for this study, was the best single predictor of the premature 
discharge of recruits from the BMT of the Air Force (Klesges et al., 2001).  
 Despite the anti-tobacco measures implemented in recent years, such as the 
free-of-charge tobacco treatments, the regulation of the prices of the tobacco products, 
and the designation of military buildings as smoke fre ; the smoking trends among the 
active duty military personnel in the United States r main high and present an 
increasing trend that is remarkably higher compared to civilians (Haddock et al., 
2009). The study was conducted with the aid of 15 focus groups from four USAF 
installations and nine focus groups from two U.S. Army installations, and was 
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concentrated on junior enlisted personnel and on thse who directly supervise them, 
aged from 18 to 24 years old (Haddock et al., 2009). The results demonstrated that the 
factors that encourage tobacco use among junior enlist d ranks were smoke breaks, 
the easy access to tobacco products in the military installations, the social 
attractiveness of smoking, anxiety and boredom, and the apprehension of gaining 
weight. On the other hand, the factors that discourage tobacco use were the severe 
smoking bans in all military installations and vehicles, the inconvenience of smoking 
in designated areas, and the influence of the supervisors (Haddock et al., 2009).  
 Another study, published in 2009, focuses on the reasons for tobacco use 
among soldiers of U.S. Army. Soldiers in the Army use tobacco in order to fight 
stress, relax, socialize and make friends. Moreover, th  majority of the soldiers in this 
study believed that the use of tobacco could help them to face the psychological and 
physical anxieties derived from the requirements of training and deployment. Some of 
them used tobacco products because of issues related to boredom and sleep 
deprivation (Nelson et al., 2009). Some of them used Smokeless Tobacco (SLT) as a 
less harmful alternative to smoking, despite being well aware of the adverse 
relationship between SLT and oral health (Nelson et al., 2009). In conclusion, the 
study suggests that the Army regulations and smoking restrictions should be more 
severe regarding the use of SLT. The team of Haddock et al. conducted a study in 
2001, using the entire population of the Air Force Basic Military Training recruits for 
the period August 1995-August 1996, focusing on the use of smokeless tobacco 
among this population. The conclusions of this survey revealed that SLT is a powerful 
predictor of smoking initiation and the users of SLT appeared to be more susceptible 
to risky behaviors, such as dangerous driving (driving while intoxicated, not using 
seat belts) and the usage of alcoholic beverages (Haddock et al., 2001).  Those who 
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tended to make extensive use of SLT were caucasians, while minorities were less 
likely to use SLT. SLT is used more frequently by recruits with high-income 
household backgrounds, suggesting that low income may be a barrier to the use of 
SLT (Haddock et al., 2001). The main finding of theresearch was the ascertainment 
that SLT is a strong predictor for tobacco use initiation, and that anti-smoking and 
cessation regulations and measures should include strat gies that ban the use of SLT 
among the ranks of the Air Force (Haddock et al., 2001).  
 Many U.S. military personnel report fighting stress with smoking. Stein et al. 
investigated the relationship between high levels of stress and tobacco use among 
active duty members of the U.S. military, using the survey of Health-Related 
Behaviors of the DoD administered during the period September 2002 – February 
2003. The study demonstrated that individuals that smoke or use smokeless tobacco, 
reported combating higher levels of stress related to family and work issues, 
compared to former or never smokers (Stein et al., 2008). Also, 18.39% of the 
participants were experiencing stress related to deployment, 15.52% were facing 
problems with a coworker, 15.42% were having problems with a supervisor, while 
7.82% were combating stress derived from relationships. Finally, 6.24% reported 
stress because of health problems (Stein et al., 2008). In all cases, tobacco users were 
more susceptible to other negative behaviors, such as drinking alcohol and careless 
driving compared to non smokers (Stein et al., 2008). The studysuggested that tobacco 
use as a method for coping with stress is not effectiv  and smoking makes an 
individual less likely to use “positive coping strategies.”   
Another study, similar to the above mentioned, cites the relationship between 
cigarette smoking and military deployment, based on analyses conducted during the 
period of March 2007 – April 2007. Smith et al. in their study mention that 
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deployment is a decisive factor for smoking initiaton and particularly for smoking 
recidivism. Among individuals that had never smoked b fore, 2.3% began smoking 
after deployment, while among former smokers, the percentage of those who reported 
resumption of smoking after deployment was 39.4%. The total percentage of smoking 
increase after deployment was 57% (Smith et al., 2008).  
 A team of researchers attempted to evaluate the smoking status and the status 
of tobacco use cessation (TUC) policies implemented for active duty members of the 
DoD, using and analyzing data collected from a new Military Treatment Facility 
(MTF) TUC evaluation tool in 2007. The study reported hat, in 1997, $20 million 
was spent for medical care expenses associated with smoking for active duty AF 
personnel, and their cost of lost productivity for the same year due to smoking reached 
$87 million (Fraser et al., 2009).  
In 2004, the medical cost of smoking to the DoD accounted for $1.3 billion, 
while a more recent study mentions that the annual cost to the DoD of tobacco use, 
comprised of healthcare expenditures, lost productivity, and decreased readiness, 
amounts to $1.6 billion (Fraser et al., 2009).  Thestudy focuses more on the smoking 
trends among the active duty members of the DoD for 2007 and compares them to the 
corresponding civilian members. The resulting investigation showed that the 
percentage of current smokers among the active duty personnel of the DoD for 2007 
was 19.1%, slightly lower than the percentage of current smokers of the general 
population of the country for the year 2006, which was 20.8% (Fraser et al., 2009). 
Valuable information can be extracted from this study, concerning the rates of lifetime 
smoking, current smokers, everyday smokers and someday smokers for the Air Force 
(AF) for the year 2007, which are compared to the corresponding rates of the total 
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Military Health System (MHS) and the CDC National Benchmark rates, according to 
a survey executed in 2006. These rates are given in Table 3.  
 
Table 3. CY 2007 Prevalence Smoking Rates (Fraser et al., 2009) 
 
Prevalence Smoking 
Rates Computed for: 
 
AF 
 
MHS 
CDC 
National Benchmark 
Lifetime Smoking 40.7% 46.7% 50.2% 
Current Smokers 16.1% 19.1% 20.8% 
Everyday Smokers 64.1% 66.3% 80.1% 
Someday Smokers 32.9% 33.7% 19.9% 
 
The percentage of users of smokeless tobacco for the Air Force in 2007 was 
4.5%, while the prevalence of smokers and users of sm keless tobacco at the same 
time was 0.9% (Fraser et al., 2009).  The study emphasizes the fact that despite the 
implementation of several tobacco controls and cessation programs, the percentages 
of smokers in the DoD still remain high, and suggests a series of recommendations. 
The tobacco control policy of the DoD should be update , including more severe 
policies such as the pricing of tobacco products sold in military facilities. Moreover, 
there should be an “inter-departmental communication” among the several forces of 
the DoD, for an enhanced collection of data, concerning the efficacy of the several 
anti-tobacco policies and the medication used in them (Fraser et al., 2009).  The 
Medical Treatment Facilities (MTFs) should apply a more scrutinized observance of 
the Nicotine Replacement Therapy (NRT) and non-NRT medications and of their 
results, and perform cost-benefit analyses which would provide beneficial information 
about the quit rates and the effectiveness of these therapies (Fraser et al., 2009).  
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 The most recent study about smoking and its associati n with mental health 
disorders among active duty military members was released in February 2011. This 
study used data from the 2005 DoD Survey of Health Related Behaviors (HRB) 
Among Active Duty Military Personnel in order to extract information regarding the 
smoking trends among the four forces of the U.S. military, and the relationship 
between smoking and mental health. The survey was based on a population of 13,603 
subjects and the majority of the population was aged between 21 and 34 years old. 
Sixty-six percent of the population consisted of White, non-Hispanic individuals, 44% 
had some college education, 44.6% of the respondents were not married and 49.2% of 
the respondents were married with their spouse at home. Moreover, the biggest part of 
the population comprised of enlisted subjects, 82.2%, and 56% of them that had been 
deployed in the past three years (Schroeder, 2011). The results, regarding the smoking 
trends among the four forces of the U.S. military, showed that the Army had the 
highest prevalence of smoking at 31.9%, while the Marine Corps accounted for the 
lowest percentage of smoking prevalence with 12.9% (Schroeder, 2011).   
Regarding the association between mental health and smoking, the 
respondents that had received mental counseling in the past were 67% more likely to 
smoke. The study reports that the ranks of officers were less likely to smoke 
compared to the enlisted ranks. In addition, the survey makes a reference to the 
association of smoking and some behavioral characteristics, such as the usage of 
alcohol and the absence of physical exercise. The respondents who reported being 
“heavy drinkers” were over four times more likely to be smokers, while those who 
didn’t perform a workout at least 3 times a week had an increased likelihood of 
smoking (Schroeder, 2011).  The study underscores the medical and occupational 
morbidity for the active duty members of DoD caused by mental disorders and their 
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association to smoking. This morbidity could be contr lled and subsequently 
decreased by providing increased support in the field of diagnosis and treatment of 
mental disorders and by launching a more drastic smoking cessation policy for the 
members of the DoD (Schroeder, 2011).  
 Another report, prepared by the Research Triangle I stitute (RTI) reported that 
the prevalence of cigarette use in the DoD population in 2005 was 32.2%, while the 
Air Force had the lowest percentage of prevalence of igarette use, 23.3%, compared 
to the Army, Navy and Marine Corps (Bray et al., 2006).  Male smokers exceed 
female smokers with 33.5% versus 24.2% prevalence. Among racial groups, Whites, 
non–Hispanics are most likely to smoke (36%). Moreover, individuals with an 
education level of high school or less are more susceptible to cigarette smoking. 
Marital status affects smoking, too, as unmarried participants of the study represent 
the highest percentage of smokers, 38.1%. The lowest pay ranks of E1 to E3 had the 
highest prevalence of cigarette use, 45.9%, almost ten times larger than the 
corresponding prevalence for the pay ranks of O4 to O10 (Bray et al., 2006). For the 
Air Force, 14.5% of the respondents reported they started smoking after joining, while 
39% of the current smokers among the active duty members confessed they started 
smoking after joining the Air Force (Bray et al., 2006). Thirty-three percent of the Air 
Force respondents reported that the availability of tobacco products in Air Force 
installations makes it easy for someone to smoke, and among the reasons that explain 
cigarette use, 24.7% of the Air Force participants of the study, which was the highest 
rate, reported cigarette use in order to relax and calm down (Bray et al., 2006).  
A significant issue related to smoking is the productivity loss within the DoD. 
Smokers present a higher productivity loss compared to the rest of the population, and 
the most frequent types of productivity loss are “leaving work earlier, being late for 
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work by 30 minutes or more, and working below normal performance level” (Bray et 
al., 2006).  Moreover, smokers are more susceptive to working accidents than 
nonsmokers.   
 The most recent data available for current smoking rates is for 2008 and notes 
that the current smoking prevalence among military personnel is 31%, a rate which 
remains mostly steady since 2002. The main contributing factors that keep this rate 
unchanged for the last year are stress, deployment, boredom, the easy access to 
tobacco products, and  in some cases sleep deprivation. Among the four services of 
the U.S. military, the Marine Corps present the highest prevalence of smoking, 37%, 
and Air Force the lowest at 23%. Rates referring to the use of smokeless tobacco in 
the DoD show the Air Force to hold the lowest rate of 9% and the Marine Corps the 
highest rate, 22%. The majority of smokers in the DoD are male, single, White, 
enlisted, and between the ages of 18 and 20 years old, and usually of low education 
level. The goal of the DoD was to implement an anti-smoking policy that could 
decrease the smoking prevalence to below 12% by 2010, but this has not been 
managed.  The Air Force has applied the most severe tobacco control and cessation 
measures of all the branches of the U.S. military, including the ban of smoking during 
Basic Military Training, restricting smoking to very specific areas, and the prohibition 
of smoking advertisements in Air Force publications (Legacy for Longer Healthier 
Lives, 2011).  
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III. Data and Methodology 
Overview 
 The purpose of this chapter is to define and delineate the data sets and 
methodology used to answer the research questions formulated in Chapter I. This 
chapter will start with a discussion related to the data sets used for this research, how 
the data were aggregated and used and what kind of conclusions and information was 
extracted from each of them.  The next step will be to discuss what kind of analysis 
was used in each data set in order to answer the research questions. This analysis 
follows the partition of the research questions, since this partition is compatible with 
the nature of the data sets and their use. Next, each analysis will be further analyzed 
and presented in a more meticulous way, since each analysis answers questions of 
different nature.  
In the first data set we have a Contingency Analysis followed by a graphical 
presentation of Excel diagrams, while in the second data set we have a Multiple 
Regression analysis. The second case is more complicated since the dependent 
variable, which is the cost of hospitalization of active duty members of the United 
States Air Force, hospitalized because of diseases related to smoking, is explained by 
many independent variables associated with age, gender, pay rank, and the frequency 
of the appearance of the most prevalent diseases related to smoking which present the 
highest cost. The second data set is used, additionally, to elicit information related to 
the cost of the diseases and to compose a list of the ten most “expensive” diseases. 
The frequency of the appearance of the diseases, mention d in this list, is used as one 
of the independent variables in the regression models, which are built in order to 
explain how the cost is affected by the age, gender, pay rank and the diseases 
themselves. Lastly, the regression models will be further discussed, focusing on which 
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variables are used and why, how the variables were formed, and which diagnostics 
tests were used, in order that the validity of the models is better explained.  
Data Sources  
 Two data sets were used in this research in order to deduce the results needed 
to answer the research questions. The first data set is a data set based on the Air Force 
Web Health Assessment (AF Web HA) questionnaire, answered by active members of 
the Air Force, throughout the years 2005 – 2009. The Web HA questionnaire is a part 
of the annual Preventative Health Assessment (PHA) exam and it is mandatory for all 
Active Duty Air Force members. It is divided into 17 sections, covering demographics 
and all the health issues for the member.  This research is focused on sections 1 and 8, 
which are Demographics and Tobacco Use. The data set was provided by the 
Healthcare Informatics Division, AF/SG6H in San Anto io Texas, in November 2010, 
and includes information for the period from 2005 to 2009. This data set is used for 
the Contingency Analysis and the formulation of the smoking rates among the AF 
active duty members according to age, gender and pay rank.   
 The second data set is a cost data set, presenting the cost of hospitalization 
(expressed in Then Year dollars) of the active duty members of Air Force due to a 
disease related to smoking, throughout the period 1999 – 2009.  The cost data set was 
obtained from the Air Force (AF) Medical Support Agency’s Healthcare Informatics 
Division (AFMSA/SG6H), located in San Antonio, Texas. The data came from direct 
care (on base, either inpatient or outpatient) and network care (off-base, provided by 
non-military medical providers). Any on-base cost da a is determined using MEPRS 
(Medical Expense and Performance Reporting System) criteria. All off-base cost data 
represent what is charged to Tricare. For each individual of this data set, there is an 
ICD-9 code in column Diagnosis 1, which refers to the primary diagnosis for the 
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patient. There are 8 more columns named Diagnosis 2, Diagnosis 3 up to Diagnosis 9 
and include additional information, based on ICD-9 coding, about secondary 
diagnoses. This research is based on the Diagnosis 1 (primary diagnosis) for the most 
prevalent diseases related to smoking, according to the assumptions presented in 
Chapter I.   
Furthermore, the data set takes into consideration dditional information such 
as age, gender, and pay grade of the patient and of course the current year, 
information that is composed of the independent variables of the regression models 
built with this data set. The range of cost fluctuates between $0.00 and $307,063.12, 
which created an initial problem in the distribution f the Y response, which in this 
case is the Cost. In Appendix B, the primary distribution of Cost is shown and it is 
apparent that many outliers exist that make the data set seem erroneous and indicate a 
poorly fitting regression line. Avoidance of these outliers led to the partitioning of the 
primary data set into 5 subsets. The result of this partition was the creation of the 
following 5 subsets presented in Table 4:  
 
Table 4: Five Subsets and their Range of Cost  
 
Five Subsets 
Number of Subset Description  Cost Range in $  
1 Low Cost $0.00 - $600.00 
2 Medium Cost $600.01 – $1,800.00 
3 High Cost $1,800.01 – $11,000.00 
4 Very High Cost $11,000.01 - $30,000.00 
5 Extremely High Cost $30,000.01 – 307,064.00 
 
42 
 The partition of the initial data set and the creation of 5 subsets lead to the 
structure of 5 regression models, one for each subset. The development of 5 
regression models corresponding to different ranges of cost, verified evidence that for 
different levels of cost there are different variables affecting the Y response (cost).  
 In addition, the second data set of cost was used in a Pivot Table Analysis, for 
the extraction of additional information about the cost of hospitalization due to 
smoking and its correlation to several socio-demographic characteristics of the Air 
Force population and to the most prevalent diseases related to smoking. The 
procedure and the purpose of the Pivot Table Analysis are further analyzed later in 
this chapter.   
Normalization of the Cost Data Set   
 The second data set, used for building the regression models, is a data set of 
the cost of the hospitalization expressed in Then Yar Dollars, which are dollars that 
include the effects of inflation and/or reflect the price levels expected to prevail 
during that year (SCEA, 2011). 
The comparison of cost over the course of many years demands the conversion of 
Then Year Dollars to Constant Year Dollars. Constant year Dollars are a method of 
comparing dollar amounts of several years, without the effects of inflation. In this way 
the dollar amounts are showed at the value they would have in a selected Base Year. 
The Constant Year Dollars method includes the division of Current Year Dollar 
estimates by appropriate price indices. This procedure is also known as deflating 
(SCEA, 2011).  The conversion from Then Year to Consta t Year Dollars is used to 
present the value of something over time, excluding the effects of inflation or 
deflation. This enables the researcher to compare cost over time and to normalize the 
data set and make it more eligible for regression analysis. The method used for 
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converting the Then Year Dollars to Constant Year Dollars was based on the Inflation 
Calculator of the Air Force. The Inflation Calculator of the Air Force is a tool, which 
allows the user to generate any desired set of inflat on tables, for any base year, 
starting from the year 1949 and ending at the year 2060. This calculator enables the 
user to perform inflation conversions without using i flation tables, or, to generate the 
Inflations tables and use them in order to execute the appropriate conversions. In 
addition, the inflation tables generated by this calcul tor include all types of expenses 
of the Air Force and both the Raw and Weighted inflation indices.  
The method used in this research for converting the Then Year to Constant 
Year Dollars was based on first generating the Weight d Inflation Indices, using the 
year 2009 as the Base Year. For this specific conversion (Then Year to Constant Year 
Dollars) it is appropriate to use the weighted indices. The cost data set of this research 
has a range of 11 years, from 1999 to 2009. The last year was used as the Base Year. 
The use of 2009 as Base Year converts all the Then Year Dollars to 2009 Constant 
Year Dollars. The category of expenses used in this research is Operations and 
Maintenance (3400), which incorporates the medical expenses for the members of Air 
Force. The Air Force Inflation Calculator was used in this research for generating the 
Weighted Inflation Indices for Operation and Maintenance (3400), for the period 1999 
– 2009, using the year 2009 as the Base Year. These inflation indices are given in 
Table 5.  
 
 
 
 
44 
Table 5. USAF Weighted Inflation Indices Based on OSD (Office of the 
Secretary of Defense) Raw Inflation Rates - Base Year (FY) 2009  
 
Fiscal Year  Operations & Maintenance (3400)  
1999 0.831 
2000 0.843 
2001 0.855 
2002 0.863 
2003 0.876 
2004 0.897 
2005 0.929 
2006 0.952 
2007 0.976 
2008 0.995 
2009 1.007 
 
After generating the inflation indices with the year 2009 as Base Year, the 
second step in the process of converting the Then Year Dollars to Constant Year 
Dollars is locating the weighted index that corresponds to the Then Year of the 
provided dollar amount. The third step is the division of the provided dollar amount 
by this weighted index. For example a dollar amount of $100 in Then Year Dollars of 
1999 could be converted into Constant Year Dollars of 2009 by dividing the amount 
of $100 by the weighted index of 1999. Using Table 5, the amount $100 must be 
divided by 0.831. The division of $100 by 0.831 equals $120.34 ($100/0.831 = 
$120.34) and thus the 1999 Then Year Dollars is converted into 2009 Constant Year 
Dollars. This method of conversion was used for converting the whole cost data set 
from Then Year Dollars to 2009 Constant Year dollars.  
Contingency Analysis  
 The first data set, based on the AF Web HA questionnaire, was used to detect 
if there is a relationship between smokers (dependent variable) and pay rank, gender, 
or age (independent variables). For this purpose, the Contingency Analysis of nominal 
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variables was used, determining if a relationship ex sts between two nominal 
variables. Other statistics such as t-tests, regression  and so on, apply to dependent 
variables that are continuous.  
The Contingency Analysis structures the data into a two-way table showing 
the groupings for each of two different variables. Once the contingency table 
has been constructed, it is easy to examine if the two variables are 
independent. The statistical test to use in this case is the chi-square test for 
independence. (Treloar, 2009) 
 
The null hypothesis is that the two variables are independent. In case that the null 
hypothesis is rejected, when the chi-square value is large and the corresponding p-
value is low, then a relationship between the two variables is identified.  
 JMP®, the statistical tool used in this research, when conducting the 
Contingency Analysis of two nominal variables, produces the Mosaic Plot, the 
Contingency Table and the Tests Report. The Tests Report gives the negative log-
likelihood for categorical data, the Degrees of Freedom and the R-square (U) value. 
But the most important part of the Tests Report is the two Chi-square statistical tests 
of the hypothesis. “The Likelihood Ratio Chi-square test is computed as twice the 
negative log-likelihood for Model in the Tests table. The Pearson Chi-square is 
another Chi-square test of the hypothesis that the response rates are the same in each 
sample category.” (JMP, 2007) The Mosaic Plot is divided into small rectangles and 
each rectangle is proportional to a frequency count f interest, and in this research 
each rectangle shows the size of smokers and non smkers for each relative group 
(pay rank, gender and age), depending on the X-variable used each time. The 
Contingency Table appears as a simple two-way frequency table and for each factor 
level of the X-variable there is a row (like two rows for gender, one for males and one 
for females) and a column for each response level of the Y response (in this research 
there are two columns, one for the smokers and one for the non smokers). The 
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Contingency Table provides cell quantities, such as Count, Total%, Row%, Col%, 
and Expected which were used (in the Microsoft Excel® tool) in this research for a 
more graphic presentation of the smoking rates in Air Force and how these rates are 
affected by pay rank, gender, and age.  
Pivot Table Analysis  
 The Pivot Tables option in Microsoft Excel® is one of the most powerful 
features of Microsoft Excel® and allows rapid, flexible, and dynamic analysis of a
data set. The Pivot Tables feature is the most appropriate and quickest way of 
summarizing lengthy data sets into a compact format. Furthermore, it is a helpful tool 
which is used to find relationships within data that are hard to discover because of the 
amount and length of data, and to organize the data into an easier format to chart. In 
this research Pivot Tables was used with the aim to summarize the cost information of 
the second data set, after having deflated,  and to reveal potential relationships 
between cost and a group of variables such as pay rank, age, gender, and diseases. The 
Pivot Table analysis was initially the leading tool for classifying the diseases 
according to their cost and answering the second resea ch question of this study. In a 
second phase, the efficiency of the Pivot Tables wa used in a very fruitful way and 
more valuable information was extracted for the compact organization of the initial 
data set. Apart from the table of the cost ranking of the diseases and the graphical 
depiction, the Pivot Table analysis enriched this research with tables and graphs 
exhibiting the total and average annual cost of hospitalization of the ADAF personnel 
and to the number of medical visits, sorted out by specific socio-demographic 
characteristics such as pay rank, gender and age, for the period from 1999 to 2009. 
Additionally, The Pivot Tables furnished this research with information which 
harmonizes with the subsequent regression analysis of the third research question.  
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Regression Analysis  
 Data Sets  
 The third research question of this study was answered using the Regression 
Analysis of multiple variables. The data set used for the regression analysis was the 
cost data, after having been deflated and converted in o Constant Year Dollars with 
year 2009 as the base year. In this data set, Cost is the Y response. One basic step, 
before defining the x variables and creating dummy variables for the development of 
the regression modeling, was to analyze the Y response (cost) and see how it looked 
like in a Histogram plot. The Distribution option i JMP® produced a histogram of 
cost response and since cost was a continuous variable, the Distribution generated a 
histogram with a bar chart and an outlier box plot. The histogram demonstrated the 
existence of outliers, which are equal to extreme values, and indicated the division of 
the initial data set into subsets of different range of cost. The result of this division 
was the partition of the data set into five subsets and the construction of 5 regression 
models, one for each subset and its correspondent range of cost.  The presentation of 
the Distribution of the initial data set and the five subsets is included in Appendix A.   
 Dependent Variable  
  The dependent variable, of the regression analysis developed in this research, 
is the cost of hospitalization of active duty members of Air Force, for the period 1999 
– 2009, because of smoking related diseases. The initial data set did not present any 
uniformity because of the great range of cost, and for this reason it was subsequently 
partitioned into five subsets, using the range of cost as criteria. In this way, five 
regression models were built, each one for a different scale of cost, but the dependent 
variable for all  the models remains the cost.  
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Independent Variables  
 The initial data set consisted of a small number of columns, which were the 
primary independent variables. Gender, age, pay rank, and primary diagnosis were the 
main columns of the data set, which were the original i dependent variables. Gender, 
pay rank and primary diagnosis were nominal variables while age was a continuous 
variable. The original independent variables were inserted into JMP and used for 
generating dummy variables, which recoded the independent variables and 
distinguished them into different treatment groups, taking the values 0 or 1 in order to 
indicate the absence or presence of some of their categorical effect. The following 
sections define each of the independent variables.  
o Age. The original independent variable ‘Age” was divi ed into five dummy 
variables, each one corresponding to a different age group. There were five 
age dummy variables for the following age groups: Age 17-24, Age 25-34, 
Age 35-44, Age 45-60 and Age 61-87.  
o Gender_1. The dummy variable Gender_1 was derived from the original 
categorical variable Gender, with the value 1 assigned to males and 0 to 
females.  
o Enlisted. This dummy variable was created from the original categorical 
variable Pay_Rank and split all the pay ranks into tw  more general 
subcategories: enlisted and officers. All the enlisted ranks were given value 1 
and the ranks of officers received value 0.  
o CD, OCS. This dummy variable derived from the original categorical variable 
Pay_Rank and ascribed value 1 to the ranks of Cadet (CD) and Officer 
Candidate School (OCS) and value 0 to the rest of the ranks.  
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o E1, E2, E3, E4. Dummy variable derived from the original categorical variable 
Pay_Rank and ascribed value 1 to the ranks of Airman Basic (E1), Airman 
(E2), Airman First Class (E3), Corporal (E4), and value 0 to the rest of the 
ranks. 
o E5, E6. Another dummy variable originated from the original Pay_Rank, 
which assigned value 1 to the ranks of Staff Sergeant (E5) and Technical 
Sergeant (E6) and value 0 to the rest of the ranks.  
o E7, E8, E9. This dummy variable was originated from the original 
independent variable Pay_Rank and attributed value 1 to the ranks of Master 
Sergeant (E7), Senior Master Sergeant (E8), and Chief Master Sergeant (E9), 
and value 0 to the rest of the ranks.  
o O1, O2, O3. This dummy variable was created from the variable Pay_Rank 
and ascribed value 1 to the ranks of Second Lieutenant (O1), First Lieutenant 
(O2), and Captain (O3), and value 0 to the rest of the ranks.  
o O4, O5, O6. Another dummy variable derived from Pay_Rank, which 
assigned value 1 to the ranks of Major (O4), Lieutenant Colonel (O5), and 
Colonel (O6), and value 0 to the rest of the ranks.  
o O7, O8, O9, O10. This dummy variable originated from Pay_Rank and 
attributed value 1 to the ranks of Brigadier General (O7), Major General (O8), 
Lieutenant General (O9) and General (O10), and value 0 to the rest of the 
ranks.  
o Diseases. This continuous variable was a derivative of the original variable 
Primary Diagnosis, and it was used as a stepping stone for the creation of the 
dummy variables, associated with the cost and the frequency of the appearance 
of the diseases. The creation of this variable demanded the use of the table 
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with the classification of the diseases according to their cost. This assortment 
was part of the research done in the Pivot Table Analysis. This variable 
contains values from 1 to 11, according to the costrating of diseases presented 
and described in the Pivot Table Analysis of Chapter IV. 
o Dummy variables for Diseases, counted from 1 to 11. These dummy variables 
were created from the above described variable “Diseases”, and they are 
associated with the cost and the frequency of appearance of the most prevalent 
diseases related to smoking with the highest cost (the eleven diseases that cost 
the most to the Air Force for the period 1999-2009, assorted by the Pivot table 
Analysis presented in Chapter IV). In each of the dummy variables, value 1 is 
attributed to the disease referred to the dummy variable, and value 0 to the rest 
of the diseases.  
 
Summary of Data  
 The section of the regression analysis used the data set of the cost of 
hospitalization of active duty members of the United States Air Force due to smoking 
related diseases, for the period 1999 – 2009. The diseases used in this analysis were 
the ones registered in Primary Diagnosis and only the most prevalent diseases 
associated with smoking. The dependent variable was the cost, which was first 
converted into Constant Year Dollars, using the weighted inflation indices with base 
year 2009, of the Inflation Calculator of Air Force. The initial data set was partitioned 
into five data subsets because of the wide range of cost and the non-existence of 
uniformity. The independent variables used for building the five regression models, 
one for each data subset, were five dummy variables for age, gender, separation of the 
enlisted and officers’ ranks; seven dummy variables for even pay rank groups; and 
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eleven dummy variables related to the cost rating and to the frequency of the 
appearance of the diseases used in this research.  
Building the Models  
 The regression analysis in this research was elaborated by applying Ordinary 
Least Squares (OLS) regression to the data subsets described previously. The OLS 
regression is the most common form of linear regression which maximizes the amount 
of explained variation in the dependent variable by minimizing the sum of squared 
distances between the observed responses in the dataset nd the responses predicted 
by the linear approximation. The general form of OLS regression is given by the 
formula below:  
yi= βo + β1x1i + β2x2i + …+ βpxpi + εi 
In this formula, yi represents the dependent variable or the response, for a specific 
observation i. The independent variables, sometimes called control variables, are 
given by x1i, x2i, …, xpi for p i observations, The coefficients of each of the p 
parameters are represented by β1, β2, …., βp and the intercept or constant term in this 
equation is given by β0. The εi represents the residual, which is the difference betwe n 
the actual and the estimated function value.  
 Search for Predictive Variables  
 The procedure used for the selection of the most predictive regressors (x 
variables) was based on the t-statistics of the regressors and their p-values. When 
regressing the model with all the regressors, the t-ratio in the Parameter Estimates, 
gives the t-statistic test for a test of the null hypothesis that βi = 0.   If the null 
hypothesis is true for a regressor xi, then this regressor has no effect on the regressant 
Y and can be deleted from the regression model. The column “Prob>|t|” in Parameter 
Estimates gives the p-values for a two-tailed test of the null hypothesis that  βi = 0. 
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Small p-values in this column sign that the corresponding regressor (x variable) does 
have an effect on the regressant Y and can be used in the regression model. In this 
research, for the OLS regression models, x variables were used whose t-statistic p-
values were less than 0.05.  
Model Diagnostics  
 The assessment of the appropriateness of a linear model, built through the 
regression analysis process, is based on some statistical ndices given by the results of 
the regression and on some diagnostic tests. The indices consist of part of the results 
of the building process of the linear model, while th diagnostic tests are done by the 
researcher, in order to assess if the model fits the data well. The following sections 
define which indices were taken into consideration and what tests have been executed 
for the assessment of the goodness-of-fit of the models, built in this research.  
 R – Squared (R2) and Adjusted R – Squared (Adj. R2)  
“By definition, R2 is the fraction of the total squared error that is explained by 
the model. Thus values approaching one are desirable. But some data contain 
irreducible error, and no amount of modeling can improve on the limiting value of R2” 
(Annis, 2008).  R2 is the relative measure of the predictability of a model and takes 
values between 0 and 1. The higher and closer to 1 the R2 is, the better the model. The 
R2 measures how well the linear model approximates th real data. Referring to the 
values the R2 can take, an R2 equal to 1 means that the regression line perfectly fits 
the data. The R2 increases as more variables are added to the model. Her  lies the 
drawback of the misleading use of the R2: an increased number of variables included 
in the model would erroneously increase the value of R2. For this reason, an 
alternative R2 is used for the assessment of a model and this is the Adjusted R2. The 
Adjusted R2 is an alternative approach of R2, but it penalizes the statistic when 
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additional variables are added to the model. The Adjusted R2 is always less than or 
equal to R2 and increases only when a new term inserted in the model improves it.  
 Influential Data Points – Cook’s Distance  
 The outcome and accuracy of a least squares regression analysis could be 
distorted by the existence of one or more influential points. Influential points are data 
points with large effect on the slope of the regression line and on the estimated values 
and p-values of the independent variables. Including a  influential point in the 
building procedure of a least squares regression model, could affect the accuracy of 
the model and distort the statistical significance of the regressors (independent 
variables). Cook’s Distance is the diagnostic test used for detecting potential 
influential points. Any data point which, in the Overlay Plot of Cook’s Distance, 
presents a value greater than 0.25, indicates that it might be a potential influential 
point and should be evaluated and eventually removed. Any points removed because 
of a large Cook’s Distance value are mentioned in Chapter IV, and the correspondent 
model has been re-built without these points and the new results are given and 
compared to the previous ones.  
 Tests for Normality and Constant Variance  
 The diagnostic test used in this research for normality of model residuals is the 
Shapiro Wilk test. The Shapiro Wilk test demands the distribution of the studentized 
residuals, which is used for the test of normality. The test is based on the null 
hypothesis that the residuals are normally distribued, and thus the data are normally 
distributed. A p-value greater than 0.05 fails to reject the null hypothesis and in this 
case, the residuals are normally distributed and the data set is well modeled. On the 
contrary, a p-value less than 0.05 rejects the null hypothesis and in this case, the 
studentized residuals are not normally distributed an the data not well modeled. 
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 The Breusch-Pagan test is used to test for homosceda ticity in a linear 
regression model. The key assumption in the Breusch-Pagan test is that the variance 
of the errors is constant across the observations. If the errors present constant 
variance, then they are called homoscedastic. For the assessment of this assumption 
the residuals are plotted and the null hypothesis is that the residuals exhibit constant 
variance. A p-value larger than 0.05 fails to reject the null hypothesis and in this case 
the errors exhibit constant variance and they are homoscedastic.   
 Multicollinearity  
  Multicollinearity occurs when two or more variable are collinear, meaning 
that they are linearly related and they measure substantially the same thing. In this 
case, the overall p-value of the model might be low but neither of the x variables 
makes a significant contribution to the model. The assessment method used for 
multicollinearity in this research is the Variation Inflation Factors (VIFs). High values 
of VIF scores, and particularly VIF scores larger than 5, mean that the fit of the model 
is affected by multicollinearity and variables with high VIF scores should be omitted 
and combined with other variables, for a better contribution to the model.  
The Final Ordinary Least Squares Regression Models  
 , Five models were built, each one corresponding to a specific subset of the 
initial cost data set and to a particular range of cost. For every model presented in 
Chapter IV, the following properties are explained:  
 
• The independent variables chosen every time and used in every model 
• Information extracted from the Parameter Estimates, such as the estimated 
coefficients of each independent variable, the standard errors, the t-ratios, the p-
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values, which must be less than 0.05 for each variable used in each model in 
order for the variable to be predictive and statistically significant, and the VIF 
scores.  
• Information extracted from the Summary of Fit Section, such as the R2 and the 
Adjusted R2, which provides information about the goodness of fit f the model 
and how well the regression line fits the real data points.   
• The overall p-value of the model, derived from the Analysis of Variance. A p-
value less than 0.05 rejects the null hypothesis that the means are the same, and 
in this case, there is significant difference between the different variables.  
• The results of the Shapiro Wilk and the Breusch-Pagan tests.  
 
 
Summary  
 This chapter outlines the methodology used for analyzing the data sets used in 
this study and presents what tools were used in each d ta set and for the investigation 
of each research question. The first research question was answered through the 
analysis of the AF Web HA data base, using the Contingency Analysis and the visual 
presentation of the results with the aid of Microsoft Excel®. The investigation of the 
other two research questions has been conducted with the use of the data set 
referencing the cost of hospitalization of active duty members of U.S. Air Force. 
Specifically, the second research question was answered through the usage of Pivot 
Tables, which supplied the research with a list of the diseases with the highest cost 
and with additional valuable information about the otal and average cost for each 
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group with specific socio-demographic characteristics. The third research question 
was investigated with the assistance of Ordinary Least Squares Regression Analysis. 
For this regression analysis the most prevalent diseases related to smoking were used, 
registered in the Primary Diagnosis, and the initial cost data set was partitioned in five 
subsets, each one corresponding to a particular range of cost.  
 The subsequent chapter, Chapter IV, presents and summarizes the results of 
each type of analysis used in this study, and answers each research question framed in 
Chapter I. Chapter V emphasizes and highlights the results obtained through the 
investigation of each research question.  
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IV.  Results and Analysis 
Overview  
 This chapter details the results of each of the methods discussed in Chapter III. 
First, the Contingency Analysis is presented with all the tables and figures extracted 
from this analysis. Information from the Mosaic Plots and from the Contingency 
Tables are used in Microsoft Excel®, in order to be presented in a more visual and 
descriptive way. Next, the Pivot Table Analysis presents a list with the most prevalent 
diseases related to smoking of the highest cost of hospitalization. Similarly, in this 
analysis, additional information related to total and average cost of groups sorted by 
age, gender and pay rank, is presented in graphs, executed with the aid of Microsoft 
Excel®.  Finally, in the Regression Analysis section of this research, the models built 
for each range of cost and their correspondent results are presented. The results will 
be focused mainly on the predictive variables and the power of predictability of each 
model. 
Contingency Analysis  
 The Contingency Analysis report shows a Mosaic Plot, a Contingency Table 
and a Tests report. The Mosaic Plot is “a graphical representation of the two-way 
frequency table of Contingency Table” (JMP 2007). The Mosaic plot consists of 
rectangles. The area of each rectangle is proportional t  the proportions of the Y 
variable in each level of the X variable (JMP 2007). The Contingency Table is a two-
way frequency table, with a row for each factor level and a column for each response 
level (JMP, 2007).  The Tests Report presents the results for two tests to determine 
whether the response level rates are the same across X levels (JMP, 2007).  In this 
chapter, the results of three Contingency Analyses ar  presented (associated to the 
three socio-demographic variables of pay rank, gender and age) and emphasis is given 
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to the two Chi-Square tests, which actually are the drivers for the existence or 
relationship between smoking and pay rank, gender and age.  
 Smokers / Non-Smokers versus Pay Rank  
 The first Contingency Analysis refers to the relationship between Smoking 
and Pay Rank. The Mosaic Plot, the Contingency Table nd the Tests Report for this 
Contingency Analysis are shown below in Figure 1.  
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Mosaic Plot 
 
 
 
 
Contingency Table 
PAY RANK by SMOKERS/NON SMOKERS 
Count 
Total % 
Col % 
Row % 
 
 
SMOKERS 
 
NON 
SMOKERS 
 
 
ENLISTED 
170521 
42.46 
87.30 
52.41 
154814 
38.55 
75.05 
47.59 
325335 
81.01 
 
OFFICERS 
24798 
6.17 
12.70 
32.52 
51466 
12.82 
24.95 
67.48 
76264 
18.99 
 195319 
48.64 
206280 
51.36 
401599 
 
Tests Report 
N DF -LogLike  RSquare (U)  
401599 1 4992.3428 0.0179 
 
Test ChiSquare  Prob>ChiSq  
Likelihood Ratio 9984.686 0.0000* 
Pearson 9791.725 0.0000* 
 
Fisher's Exact Test  Prob  Alternative Hypothesis  
Left 1.0000 Prob(SMOKERS/NON SMOKERS=1) is greater for PAY RANK=1 than 2 
Right 0.0000* Prob(SMOKERS/NON SMOKERS=1) is greater for PAY RANK=2 than 1 
2-Tail 0.0000* Prob(SMOKERS/NON SMOKERS=1) is different across PAY RANK 
 
Figure 1: Contingency Analysis of Smokers/Non-Smokers versus Pay Rank 
 
In the Mosaic Plot, Pay Rank=1 refers to Enlisted an Pay Rank=2 refers to 
Officers. Moreover, the red color represents the smokers and the blue the non 
smokers. It is visually obvious that the enlisted are more numerous than officers. In 
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addition, more than 50% of the enlisted are smokers, while the majority of the officers 
are non-smokers. See Table 6 and Figure 2.  
Table 6: Comparison of Smokers and Non Smokers for each Pay Rank 
 
 ENLISTED OFFICERS 
SMOKERS 52.41% 32.52% 
NON SMOKERS 47.59% 67.48% 
 
 
Figure 2: Comparison of Smokers and Non Smokers for each Pay Rank 
 
From the table and graph above it can be deduced that the majority of enlisted 
members smoke, while the exact opposite phenomenon is observed among the 
officers’ ranks. Only 32.52% of the officers’ population consists of smokers, while the 
non smokers represent the high rate of 67.48%.  
 The Contingency Table of Figure 1 gives a couple of percentages for the 
smoking status of the Air Force sample of the data se  used in the Contingency 
Analysis, and of each group separately. The smoking status of the sample is given in 
Table 7 and Figure 3.  
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Table 7: Smoking Status of the Air Force Population 
 
 SMOKERS NON-SMOKERS 
AIR FORCE 48.64% 51.36%  
 
 
Figure 3: Smoking Status of the Air Force Population 
 The table and graph show that 48.64% of the ADAF population of the data set 
is smoking and 51.36% is not smoking. This leads to the conclusion that the Air Force 
population is divided into two large, almost equal, groups: smokers and non smokers. 
The percentage of smokers (48.64%) consists of 42.46% enlisted and 6.17% officers.  
The distribution of 48.64% is given by Table 8 and Figure 4.  
 
Table 8: Distribution of the Smokers’ Population 
 
 ENLISTED WHO SMOKE OFFICERS WHO SMOKE TOTAL 
AIR FORCE 42.46% 6.17% 48.64% 
 
 
62 
 
Figure 4: Distribution of the Smokers’ Population 
The same picture of the distribution of the smokers’ population is given, but more 
detailed, if the smokers are considered a population of their own. The following graph 
(see Figure 5) presents this distribution. The graph shows that 87.30% of the smokers’ 
population consists of enlisted and only 12.70% of officers. The percentages are 
indeed alarming and show that smoking is more prevalent mong the enlisted.  
 
 
                        Figure 5: Distribution of the ADAF members that smoke 
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 The Tests Report, which is the last part of the Contingency Analysis of 
Smokers / Non-Smokers versus Pay Rank, gives the results of Pearson and Likelihood 
Ratio tests. Both of these test whether the two variables, in this case smoking and pay 
rank, are independent or not. Both Pearson and Likelihood Ratio tests have the same 
assumptions, and the null hypothesis here is that the variables are independent, 
meaning that there is no relationship between them, and more specifically, smoking is 
not affected by pay rank. The Chi-Square test compares the observed cell frequencies 
with expected cell frequencies, and assumes a null hypothesis that the variables are 
independent (JMP, 2007).  The expected values are calculated by multiplying the row 
total and column total, and then divide by the grand total. “The Chi-Square test is 
always valid if there are no empty cells (no cells with a cell frequency of 0), and if the 
expected cell frequency for all cells is five or greater” (JMP, 2007).   Figure 6 gives 
the Contingency Table of Smokers and Non-Smokers for each pay rank with the 
observed and expected frequencies, and the results of the Tests Reports.  
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Contingency Table 
PAY RANK By SMOKERS/NON SMOKERS 
 
Count 
Expected 
 
SMOKERS 
 
NON 
SMOKERS 
 
 
 
ENLISTED 
 
170521 
158228 
154814 
167107 
325335 
 
OFFICERS 
 
24798 
37091.2 
51466 
39172.8 
76264 
 195319 206280 401599 
 
Tests Report 
N DF -LogLike  RSquare (U)  
401599 1 4992.3428 0.0179 
 
Test ChiSquare  Prob>ChiSq  
Likelihood Ratio 9984.686 0.0000* 
Pearson 9791.725 0.0000* 
 
Fisher's Exact Test  Prob  Alternative Hypothesis  
Left 1.0000 Prob(SMOKERS/NON SMOKERS=1) is greater for PAY RANK=1 than 2 
Right 0.0000* Prob(SMOKERS/NON SMOKERS=1) is greater for PAY RANK=2 than 1 
2-Tail 0.0000* Prob(SMOKERS/NON SMOKERS=1) is different across PAY RANK 
 
Figure 6: Contingency Table and Tests Report of Smokers/Non-Smokers versus 
Pay Rank 
 
All the cells of the expected cell frequency of theContingency Table of Figure 
6 are greater than five, fact that indicates that te Chi-Square test is a valid test. 
Pearson test uses the observed and expected cell frequencies, while the Likelihood 
Ratio test uses a more complex formula (Schlotzhauer, 2007).  The column 
Prob>ChiSq gives very low p-values for both tests. These very low p-values, which 
are less than the significance level of 0.01, give enough evidence to reject the null 
hypothesis of independence between smoking and pay rank, and indicate a 
relationship between the two variables.  
The Fisher’s Exact Test is more suitable for small frequency tables and JMP® 
performs this test for 2x2 tables, but it cannot be ex cuted for larger tables. JMP® 
presents the results for both one-sided test and two-sided test. The 2-tail p-value is the 
more suitable test and tests for independence between th  two variables, and is 
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interpreted the same way as the Chi Square test. The p-value of 2-tail test is very low, 
less than the significance level, and in this case the null hypothesis is again rejected, 
meaning that a relationship between the two variables, smoking and pay rank, exists.  
 Smokers/ Non-Smokers versus Gender  
 In this Contingency Analysis, the existence of relationship between smoking 
and gender is examined. The Mosaic Plot, the Contingency Table, and the Tests 
Report of this Contingency Analysis are given below in Figure 7.  
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Mosaic Plot 
 
 
 
 
Contingency Table 
GENDER by SMOKERS/NON SMOKERS 
 
Count 
Total % 
Col % 
Row % 
Expected 
 
SMOKERS 
 
NON  
SMOKERS 
 
 
 
FEMALES 
31286 
7.79 
16.02 
36.69 
41467.5 
53976 
13.44 
26.17 
63.31 
43794.5 
85262 
21.23 
 
 
MALES 
164033 
40.84 
83.98 
51.85 
153852 
152304 
37.92 
73.83 
48.15 
162485 
316337 
78.77 
 195319 
48.64 
206280 
51.36 
401599 
 
 
 
 
Tests Report 
N DF  -LogLike  RSquare (U)  
401599 1 3123.7184 0.0112 
 
Test ChiSquare  Prob>ChiSq  
Likelihood Ratio 6247.437 0.0000* 
Pearson 6178.605 0.0000* 
 
Fisher's Exact Test  Prob  Alternative Hypothesis  
Left 0.0000* Prob(SMOKERS/NON SMOKERS=1) is greater for GENDER=F than M 
Right 1.0000 Prob(SMOKERS/NON SMOKERS=1) is greater for GENDER=M than F 
2-Tail 0.0000* Prob(SMOKERS/NON SMOKERS=1) is different across GENDER 
 
Figure 7: Contingency Analysis of Smokers/Non-Smokers versus Gender 
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 In the Mosaic Plot, the red color represents the smokers and the blue color the 
non-smokers. From the Mosaic Plot, it is easily seen and understood that the majority 
of the ADAF population are males. Furthermore, the Mosaic Plot shows that the 
majority of females in the Air Force are not smokers, while 51.85% of the male 
population is smokers. The picture of smoking status between genders in the Air 
Force is better presented by Table 9 and Figure 8.  
Table 9: Comparison of Smokers and Non Smokers for each Gender 
 
 FEMALES MALES 
SMOKERS 36.69% 51.85% 
NON SMOKERS 63.31% 48.15% 
 
 
    
  
Figure 8: Comparison of Smokers and Non Smokers for each Gender 
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The data set used for the Contingency Analysis consists of 401,599 ADAF 
members and among them, 78.77% are males and 21.23% are females. These 
numbers are taken from the Contingency Table, where more detailed information is 
provided for this study and is shown below. Since the greatest part of the Air Force 
population is comprised of males, it comes naturally that the percentage of smokers 
among the male population will be by far higher than the female population. The 
difference of the percentages of smokers between the two genders is remarkably large 
and is shown in Table 10 and Figure 9.  
Table 10: Distribution of Smokers’ Population by Gender 
 
 FEMALES WHO SMOKE MALES WHO SMOKE 
AIR FORCE 7.79% 40.84% 
 
 
 
 
Figure 9: Distribution of Smokers’ Population by Gender 
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The distribution of Smokers’ Population references the distribution of this 
population out of the whole population of the Air Force of the data set used in the 
Contingency Analysis.  This distribution shows that ou  of the total population of this 
data set, 7.79% consists of female smokers and 40.84% of male smokers. This is 
better shown if the smokers are considered a population of their own. The distribution 
of the population of the ADAF members that smoke is given below in Figure 10.  
 
 
Figure 10: Distribution of the ADAF members that smoke by Gender 
 
The graph in Figure 10 shows that 83.98% of the smoking population of the 
Air Force consists of males, and only 16.02% females. The gap between the two 
genders presented in this case is even larger, whenanalyzed according to only that 
part of the population of the Air Force which smokes.  
 The Contingency Table gives also the expected frequencies. In this 
Contingency Table, all the expected frequencies are larg r than five, and this is an 
indication that the Chi-Square test, assuming the null hypothesis that the variables are 
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independent, is a valid test. The last part of the Contingency Analysis is the Tests 
Report, where the assumption of independence between th  two variables is tested, 
which, in this case, the two variables are smoking a d gender. The null hypothesis is 
that the two variables are independent and in this case is rejected, since the p-values 
of the Pearson and Likelihood Ratio are very low and re below the significance level 
of 0.01. This leads to the conclusion that the two variables are dependent and gender 
affects the smoking status of the ADAF population. This conclusion is further 
confirmed by the 2-tail p-value shown in Fisher’s Exact Test Results. The 2-tail p-
value is really low and is less than 0.10 of the signif cance level. The null hypothesis 
in this case is again rejected and the two variables ar  dependent, meaning that gender 
does affect the smoking status of ADAF members.  
 Smokers/ Non-Smokers versus Age 
 The last part of the Contingency Analysis includes the investigation of the 
existence of a relationship between smoking and age. This section of the Contingency 
Analysis examines if age is a variable that influences smoking, by testing which age 
range of ADAF personnel smokes the most. The Mosaic Plot, Contingency Table and 
Tests Report are given below in Figure 11.  
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Mosaic Plot 
 
Contingency Table  
AGEG by SMOKERS/NON SMOKERS 
Count 
Total % 
Col % 
Row % 
Expected 
 
SMOKERS 
 
NON 
SMOKERS 
 
Age 
17-24 
55993 
13.94 
28.67 
50.81 
53598.6 
54212 
13.50 
26.28 
49.19 
56606.4 
110205 
27.44 
Age 
25-29 
48510 
12.08 
24.84 
51.46 
45844.6 
45752 
11.39 
22.18 
48.54 
48417.4 
94262 
23.47 
Age 
30-34 
31530 
7.85 
16.14 
50.00 
30667 
31525 
7.85 
15.28 
50.00 
32388 
63055 
15.70 
Age 
35-39 
26451 
6.59 
13.54 
46.54 
27643.8 
30388 
7.57 
14.73 
53.46 
29195.2 
56839 
14.15 
Age 
40+ 
32835 
8.18 
16.81 
42.51 
37565 
44403 
11.06 
21.53 
57.49 
39673 
77238 
19.23 
 195319 
48.64 
206280 
51.36 
401599 
 
Tests Report 
N DF  -LogLike  RSquare (U)  
401599 4 911.14729 0.0033 
 
Test ChiSquare  Prob> ChiSq  
Likelihood Ratio 1822.295 0.0000* 
Pearson 1816.918 0.0000* 
1= age 17 – 24 , 2= age 25-29, 3= age 30-34,  4= age 35- 39,  5= age 40 + 
 
Figure 11: Contingency Analysis of Smokers/Non-Smokers versus Age 
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 The Mosaic Plot shows the distribution of ADAF personnel according to their 
age and their smoking status. The red color corresponds to that part of the personnel 
that smokes and AGEs 1-5 correspond to different age r nges. Number one represents 
the age range from 17 to 24 years old, number 2 the age range from 25 to 29, number 
three the age range from 30 to 34, number four the age range from 35 to 39 and 
number five the age range from 40 years old and up. From the Mosaic Plot it is seen 
that the largest part of ADAF personnel belongs to the age groups of 17 to 24 and 25 
to 29, and more than half of the population of these age groups is smoking. A better 
presentation of the Mosaic Plot is given in Table 11 and Figure 12, where each age 
group is divided into smokers and non-smokers, and the distribution of the population 
of each age group is better displayed.  
Table 11: Comparison of Smokers and Non Smokers for each Age Group 
 
 Age  
17-24 
Age 
25-29 
Age 
30-34 
Age 
35-39 
Age 
40+ 
SMOKERS 50.81% 51.46% 50% 46.54% 42.51% 
NON SMOKERS 49.19% 48.54% 50% 53.46% 57.49% 
 
 
 
       Figure 12: Comparison of Smokers and Non Smokers for each Age group 
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 From Table 11 and Figure 12 it is deduced that more than half of the 
population of the first three age groups consists of smokers. Specifically, the age 
group of 30 to 34 years old is nearly evenly split between smokers and non-smokers. 
Younger age groups smoke more than middle age groups. The age groups of 35 to 39 
and 40 years and up do not smoke that much, but even in these age groups, the 
percentages of smokers are not very low.  The graph shows that almost half of the 
population of ADAF is smoking and this is alarming.  
 The Contingency Table provides valuable information which is related to 
which of the age groups smokes more and how the smoking population is distributed. 
It has been shown above, in the first part of the Contingency Analysis, that 48.64% of 
the Air Force population of the data set used in this part of this study is comprised of 
smokers. In Table 12 and Figure 13, the apportionment of 48.64% of smokers is 
displayed according to the five age groups. 
 
Table 12: Apportionment of Smokers to five age groups  
 
 ADAF 
aged 
17-24 who 
smoke 
ADAF 
aged 
25-29 who 
smoke 
ADAF 
aged 
30-34 who 
smoke 
ADAF 
aged 
35-39 who 
smoke 
ADAF 
aged 
40+ who 
smoke 
 
Total 
Air 
Force 
13.94% 12.08% 7.85% 6.59% 8.18% 48.64% 
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Figure 13: Apportionment of Smokers to five age groups  
 
 Figure 13 displays graphically the apportionment of smokers to five age 
groups and it is shown that the age group that smokes more than the others is the age 
group of 17 to 24 years old. On the other hand, the group that smokes the least is the 
one referencing the ages from 35 to 39 years old. In Table 12, where the percentages 
of smokers for each age group are presented, one can see that the percentages of 
smokers corresponding to the age groups of 17 to 24and 25 to 29 are close to each 
other and together they constitute 26.02% of the smoking population out of the whole 
ADAF population of the data set.  This is alarming for those who investigate and 
research the smoking issue in Air Force. More attention should be given to the young 
age ranges, where smoking is most prevalent. 
 The same picture of the smoking population is given, if smokers of the Air 
Force are considered a population of their own. The following Table 13 and Figure 14 
show in a more detailed way the distribution of the ADAF personnel that smokes 
according to the five age groups.  
75 
 
Table 13: Distribution of the ADAF members that smoke to five age groups 
 
 Age 
17-24 
Age 
25-29 
Age 
30-34 
Age 
35-39 
Age 
40+ 
SMOKERS 
(ADAF WHO SMOKE)   
 
28.67% 
 
24.84% 
 
16.14% 
 
13.54% 
 
16.81% 
 
 
Figure 14: Distribution of the ADAF members that smoke to five age groups 
 
 Table 13 and Figure 14 give a more detailed picture of the distribution of the 
part of the ADAF personnel that smokes. The age group that smokes more than the 
others is the age group of 17 to 24 years old and the group that smokes the least is the 
group of 35 to 39 years old. If the percentages of smokers from the age groups 17 to 
24 and 25 to 29 years old are added together, they constitute 53.51% of the smoking 
population of the Air Force. This means that more than half of the population of 
smokers in the Air Force consists of young people from 17 to 29 years old. The most 
productive part of the population of the Air Force is the group that smokes the most 
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and this is exceptionally alarming for the future health and quality of the USAF 
personnel.   
 In this Contingency Analysis, all the expected frequ ncies displayed in the 
Contingency Table, are larger than five, fact that points out that the Chi-Square test, 
testing the independence between the variables with the null hypothesis that the 
variables are independent, is a valid test. In the section of Tests Report, there is no 
Fisher’s Exact Test Results, since in this case there is no a 2x2 Contingency Table. 
The Tests Report includes only the Pearson and Likelihood Ratio p –values. Both 
Pearson and Likelihood Ratio p-values are very low and less than the significance 
level of 0.01. There is enough evidence to reject the null hypothesis of independence 
between the two variables, where in this part of the Contingency Analysis, the two 
variables are smoking and age. Smoking and age are dep ndent and this means that 
age influences the smoking status of the ADAF personnel.  
Pivot Table Analysis  
 The Pivot Table Analysis is based on another data set, which includes the cost 
of hospitalization of ADAF personnel due to diseases related to smoking. As 
mentioned in Chapter III, this data set was restricted to the most prevalent diseases 
related to smoking according to SAMMEC, and in thisstudy only those diseases that 
had been registered in the Primary Diagnosis were used. The range of time of this data 
set covers the period from 1999 to 2009, and all the dollar values associated with the 
total cost of hospitalization because of diseases related to smoking, are expressed in 
Constant Year Dollars with base year as the year 2009. The Pivot Table Analysis 
begins with the presentation of a hierarchical list of the diseases with the highest cost, 
which is used later in the Regression Analysis for the creation of Dummy Variables. 
Furthermore, the same data set can be manipulated very easily with the aid of Pivot 
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Tables, a tool of Microsoft Excel®, tables and graphs are created, displaying 
additional information about the cost of hospitalizt on through the period 1999-2009 
and the total and average cost of hospitalization for groups with specific socio-
demographic characteristics related to age, gender, and pay rank.  
 Most Prevalent Diseases Related to Smoking and their Cost 
 As mentioned before, the data set used in the Pivot Table and Regression 
Analysis was narrowed to the most prevalent diseases related to smoking, according 
to a list of 18 diseases provided by SAMMEC. The total cost of hospitalization of 
those diseases was added throughout the years 1999-2009, and the result of this 
summation was the following list of the most prevalnt diseases related to smoking 
with the highest cost, given in Table 14. 
Table 14: Most Prevalent Diseases Related to Smoking with the Highest Cost 
 
 MOST PREVALENT 
DISEASES RELATED TO 
SMOKING WITH THE 
HIGHEST COST 
HIERARCHICAL RANK OF THE 
MOST PREVALENT DISEASES 
RELATED TO SMOKING 
ACCORDING TO THEIR COST 
ISCHEMIC HEART DISEASE $22,195,207.61 1 
CEREBROVASCULAR 
DISEASE 
$14,792,633.79 2 
MALIGNANT NEOPLASMS 
OF TRACHEA, LUNG, 
BRONCHUS 
$2,069,133.88 3 
MALIGNANT NEOPLASMS 
OF LIP, ORAL, CAVITY, 
PHARYX 
$1,863,827.99 4 
OTHER HEART DISEASE $1,548,527.68 5 
MALIGNANT NEOPLASMS 
OF KIDNEY AND RENAL 
PELVIS 
$1,445,977.67 6 
MALIGNANT NEOPLASMS 
OF URINARY BLADDER 
$1,038,325.76 7 
BRONCHITIS, EMPHYSEMA $968,831.96 8 
MALIGNANT NEOPLASMS 
OF PANCREAS 
$753,908.61 9 
OTHER ARTERIAL DISEASE $743,624.50 10 
OTHERS $1,773,335.43 11 
 
 From Table 14, it is deduced that the most “expensiv ” disease related to 
smoking is ischemic heart disease, with a cumulative cost of $22,195,207.61 
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throughout the years 1999-2009.  The second place in the list is occupied by the 
cerebrovascular disease, with a cumulative cost of $14,792,633 for the period 1999-
2009.  It is seen that between these two diseases with the highest cost, there is a gap of 
approximately $12,000,000, which is a remarkably big gap. Ischemic heart disease is 
by far the disease with the highest cost because it i  the most prevalent disease related 
to smoking compared to the rest of the diseases related to smoking. The rest of 
diseases present a cumulative cost of less than $2,000,000. This cost difference 
between ischemic heart disease and the rest of the diseases emphasized the 
importance that should be given to the prevention of this disease. Row 11 in the 
hierarchical ranking of the diseases includes the rest of the SAMMEC most prevalent 
diseases related to smoking and these diseases are presented in Table 15.  
 
Table 15: Other Most Prevalent Diseases Related to Smoking  
 
OTHER MOST PREVALENT RELATED TO  
SMOKING DISEASES  
ATHEROSCLEROSIS 
MALIGNANT NEOPLASMS  
OF ESOPHAGUS 
MALINGNANT NEOPLASMS  
OF CERVIX UTERI 
PNEUMONIA, INFLUENZA 
CHRONIC AIRWAY OBSTRUCTION 
AORTIC ANEURYSM 
MALIGNANT NEOPLASMS  
OF STOMACH 
MALIGNANT NEOPLASMS 
OF LARYNX 
 
 The classification of the most prevalent diseases related to smoking according 
to their cumulative cost for the period 1999-2009, with number one being the disease 
with the highest cost, is used in the Regression Analysis of this study for the creation 
of dummy variables. These dummy variables are used a  regressors, trying to see 
which diseases affect the overall cost. The dummy variable of disease one refers to 
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ischemic heart disease, the dummy variable of disease two refers to cerebrovascular 
disease and so on, and the dummy variable of disease 11 refers to the list of the rest of 
the most prevalent diseases related to smoking. A graphical presentation of the 
diseases and their classification according to their cost is given by Figure 15.  
 
Figure 15: Most Prevalent Diseases Related to Smoking with the Highest Cost 
With the aid of the graph, the cost gap between ischemic heart disease and the 
other diseases is visually presented.  The total cost of all of the diseases, for the period 
that covers the years from 1999 to 2009, reaches the amount of $49,193,334.  The 
distribution of this amount throughout the 11 year pe iod from 1999 to 2009 is given 
by Table 16 and in a graphic by Figure 16.     
 
 
80 
 
 
Table 16: Total Annual Cost of the Most Prevalent Diseases Related to 
Smoking for the period 1999-2009 
CY TOTAL ANNUAL COST  
1999 $905,758.27 
2000 $2,986,421.97 
2001 $3,932,715.58 
2002 $3,900,035.24 
2003 $2,221,221.96 
2004 $5,257,462.32 
2005 $5,496,775.31 
2006 $5,631,356.73 
2007 $6,787,907.41 
2008 $7,106,103.24 
2009 $4,967,576.85 
GRAND TOTAL  $49,193,334.87 
 
 
Figure 16: Total Annual Cost of the Most Prevalent Diseases related to 
smoking for the period 1999-2009 
 
 The graph in Figure 16 shows that the year with the highest total annual cost 
of hospitalization for ADAF members was 2008, where th  total annual cost reached 
the amount of $7,106,103. The total annual cost and the grand total cost (the total cost 
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for the period 1999-2009) of hospitalization for males is remarkably higher than the 
corresponding one for females. Table 17 and Figure 17 give a better picture of the 
total annual cost for each gender.  
 
Table 17: Total Annual Cost per Gender 
TOTAL ANNUAL COST 
FEMALES MALES 
1999 $125,110.65 $780,647.62 
2000 $389,391.21 $2,597,030.76 
2001 $435,860.60 $3,496,854.98 
2002 $534,830.03 $3,365,205.21 
2003 $207,179.58 $2,014,042.39 
2004 $398,987.13 $4,858,475.18 
2005 $579,500.25 $4,917,275.06 
2006 $568,850.70 $5,062,506.02 
2007 $830,986.43 $5,956,920.97 
2008 $1,510,656.23 $5,595,447.01 
2009 $598,674.02 $4,368,902.83 
Grand Total $6,180,026.84 $43,013,308.03 
 
 
Figure 17: Total Annual Cost per Gender 
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Throughout the years 1999-2009, the cost of hospitaliza ion for the male 
population of the Air Force is always higher than the corresponding cost for the 
female population. Hospital expenses for males reach d their maximum in 007 
($5,956,920), while analogous expenses for females reached their maximum in 2008 
($1,510,656). In 2008, hospital expenses for female ADAF surpassed the limit of 
$1,000,000 for the first time.  
 The average cost of hospitalization for each gender is almost the same, and in 
one year, the average cost regarding females was higher than that one regarding 
males. There is no major difference between the grand average cost (the average cost 
for the period 1999-2009) for both genders. The following Table 18 and Figure 18 
show the average annual cost per gender, while Table 19 and Figure 19 present the 
grand average cost per gender. 
                        Table 18: Average Annual Cost per Gender  
 
AVERAGE  ANNUAL  COST 
FEMALES MALES 
1999 $1,097.46 $1,107.30 
2000 $1,035.61 $1,057.42 
2001 $945.47 $1,202.08 
2002 $936.66 $996.21 
2003 $3,092.23 $4,178.51 
2004 $1,461.49 $2,809.99 
2005 $2,138.38 $2,676.80 
2006 $1,644.08 $2,387.97 
2007 $1,486.56 $2,018.61 
2008 $2,452.36 $1,925.48 
2009 $1,153.51 $1,575.51 
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Figure 18: Average Annual Cost per Gender 
 
Table: 19: Grand Average cost per Gender  
 
 FEMALES MALES  
 
GRAND AVERAGE COST 
 
$1,480.96 
 
$1,774.04 
 
 
Figure 19: Grand Average cost per Gender  
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The  above tables and figures present the average annual cost and the grand 
average cost per gender. In all cases, it is ascertain d that the average annual costs for 
both genders are very close to each other. The average annual cost for males is always 
slightly higher than females, but in the year 2008, the female average annual cost 
surpassed the cost for males. The best way to measure nd compare the average cost 
for each gender is the grand average cost per gender, which is the average cost for 
each gender for the whole period of 1999-2009. The graph in Figure 19 displays the 
bar chart of the grand average cost for each gender and is is shown that both genders 
do not differ that much concerning the average costof hospitalization.  It is 
understood that even though men are a larger portion of the military population, the 
average cost is almost the same for both men and women and the expenses of 
hospitalization do not differ considerably.  
Another way to test if there is a significant difference between the average 
annual cost of each gender is the paired t-test. The paired t-test is a statistical test that 
compares the means of two groups of observations and tests to see if the average 
difference is significantly different from zero. The null hypothesis in this case is that 
there is no significant difference between the averg  annual cost of the two genders, 
and the alternative hypothesis is that there is significant difference between the 
average annual cost of the two genders.  The paired t-test for the average annual cost 
of females and males is conducted with the significance level of α=0.05. If the 
significance value of the two-tailed paired t-test is less than the significance level of 
α=0.05, the null hypothesis is rejected and there is significant difference between the 
average annual cost of the two genders. The results of the paired t-test of the average 
annual cost of the two genders are shown below in Figure 20.  
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  FEMALES MALES 
Mean 1585.801 1994.170909 
Variance 491376.5 952592.7179 
Observations 11 11 
Hypothesized Mean Difference 0 
 df 18 
 t Stat -1.12712 
 P(T<=t) one-tail 0.137246 
 t Critical one-tail 1.734064 
 P(T<=t) two-tail 0.274492 
 t Critical two-tail 2.100922   
 
Figure 20: Two-Tailed Paired T-Test of the Average Annual Cost of 
Females and Males 
 
 
It is seen in Figure 20 that the significance value of the two-tailed paired t-test 
of the average annual cost of the two genders equals to 0.274492, which is larger than 
the significance level of α=0.05. This indicates that the test fails to reject the null 
hypothesis and there is no significant difference between the average annual cost of 
females and males.  
 
 Age is another point of reference for the ADAF population.  It is worth 
investigating the cost of hospitalization due to diseases related to smoking, with age 
being the point of reference for this cost. Total and verage cost for each age group 
would be part of this investigation, and Tables 20 and 21 and Figures 21 and 22 
provide valuable information for the grand total (the total cost during the period 1999-
2009) and average cost of each age group of the Air Force population of the data set 
used for this part of the analysis. 
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Table 20:  Grand Total Cost per Age Group 
 
GRAND TOTAL COST PER AGE GROUP 
17-24 $3,330,039.14 
25-32 $5,155,190.27 
33-40 $14,090,162.82 
41-48 $18,280,958.56 
49-56 $7,059,219.94 
57-64 $1,252,358.03 
65-72 $22,817.90 
73-80 $1,391.73 
81-88 $1,196.47 
GRAND TOTAL $49,193,334.87 
 
 
Figure 21: Grand Total Cost per Age Group 
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Table 21: Average Cost per Age Group  
 
AVERAGE  COST PER AGE GROUP 
17-24 $1,423.09 
25-32 $1,524.30 
33-40 $1,602.98 
41-48 $1,854.81 
49-56 $2,099.71 
57-64 $1,920.79 
65-72 $950.75 
73-80 $173.97 
81-88 $239.29 
GRAND AVERAGE $1,731.00 
 
 
Figure 22: Average Cost per Age Group  
 
 Table 20 and Figure 21, presenting the grand totalc st for each age group, 
show that the age group 41-48 is the group with the highest cost. The second highest 
grand total cost is for the age group 33-40 and the third is the age group 49-56.  This 
classification of cost by the age groups indicates that ADAF personnel age33- 56 
years that smoke, generate the highest cost of hospitalization.  The picture of cost 
ranking by the age groups is slightly different when average cost is classified by the 
age groups. Table 21 and Figure 22 show that the age group with the highest average 
cost for the period 1999-2009 is the age group of 49-56 with an average cost of 
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$2,099.71, followed by the age group 57-64 with an average cost of $1,920.79, and 
age group 41-48 with an average cost of $1,854.81.  It is inferred that the age groups 
of 41-48 and 49-56 are the groups with the highest grand total and average cost, and 
they are the  age groups receive the most medical care due to diseases related to 
smoking. At this point it must be mentioned that the grand average cost, which is the 
general average cost of hospitalization for the whole p pulation of the Air Force of 
the data set used in this part of the analysis is $1,731.  
 The above conclusions about the total and average cost of each age group can 
be visualized also by using thefrequency of visits to the hospital or to the doctor by 
the above mentioned age groups. Table 22 and Figure 23 show the frequency of visits, 
classified by age groups. 
 
Table 22: Frequency of Visits per Age Group 
 
FREQUENCY OF VISITS 
 PER AGE GROUP 
17-24 2,340 
25-32 3,382 
33-40 8,790 
41-48 9,856 
49-56 3,362 
57-64 652 
65-72 24 
73-80 8 
81-88 5 
GRAND TOTAL 
 OF VISITS 
28,419 
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Figure 23: Frequency of Visits per Age Group 
 
The age group with the highest number of visits is the age group of 41-48, 
with the age group of 33-40 following in second place. The same groups were among 
the ones with the highest grand total and average cost. The age groups of 25-32 and 
49-56 have almost the same number of visits, and the age group of 49-56 was the one 
with the highest average cost. This classification of the frequency of visits, combined 
with the classification of grand total and average cost by the age groups, leads to the 
conclusion that smoking related diseases are most prevalent in the age range of 33 -
56. 
 Table 23 and Figure 24 give a visual presentation of the classification of 
diseases related to smoking, according to the frequency of visits (the frequency that 
ADAF personnel visited a hospital or a doctor because of a smoking related disease).   
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Table 23: Classification of Smoking Related Disease by the Frequency of Visits 
 SMOKING RELATED 
DISEASES 
FREQUENCY 
OF VISITS 
1 ISCHEMIC HEART DISEASE 12482 
2 CEREBROVASCULAR DISEASE 8133 
3 BRONCHITIS, EMPHYSEMA 1977 
4 OTHER ARTERIAL DISEASE 1005 
5 ATHEROSCLEROSIS 927 
6 MALIGNANT NEOPLASMS  
OF LIP,ORAL CAVITY, PHARYNX 766 
7 OTHER HEART DISEASE 666 
8 MALIGNANT NEOPLASMS 
 OF TRACHEA, LUNG, BRONCHUS 639 
9 MALIGNANT NEOPLASMS 
 OF KIDNEY AND RENAL PELVIS 545 
10 MALIGNANT NEOPLASMS 
 OF URINARY BLADDER 527 
11 OTHER DISEASES  752 
 
 
Figure 24: Classification of Smoking Related Diseases by the Frequency of Visits 
 
This classification of diseases differs from the prvious one showing the 
diseases with highest cost. Ischemic heart disease and cerebrovascular disease are the 
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two diseases with the highest cost and with the largest number of visits. The two 
assortments of diseases are not identical and this lead  to the conclusion that a disease 
of high cost is not necessarily a disease with a large number of visits. That means that 
some diseases cost more than others and total cost is independent of the frequency of 
visits. In this case, the category Other Diseases includes the following:  malignant 
neoplasms of cervix uteri, malignant neoplasms of es phagus, malignant neoplasms 
of pancreas, pneumonia- influenza, chronic airway obstruction, aortic aneurysm, 
malignant neoplasms of stomach and malignant neoplasms of larynx.  
 The last part of the Pivot Table Analysis includes a concentrated presentation 
of the cost of hospitalization of ADAF personnel during the period 1999-2009.  Table 
24 presents the grand total and average cost for the pay ranks of enlisted and officers 
and the grand total cost for the two genders separately.  
Table 24: Concentrating Table of Cost for each Pay Rank and Gender 
 
 ENLISTED OFFICERS GRAND TOTAL 
GRAND TOTAL COST $33,571,520.94 $15,621,813.92 $49,193,334.87 
FREQUENCY OF 
VISITS 21,103 7,316 28,419 
GRAND AVERAGE 
COST $1,590.84 $2,135.29 $1,731.00 
MALES $29,440,395.99 $13,572,912.04 $43,013,308.03 
FEMALES $4,131,124.95 $2,048,901.88 $6,180,026.84 
TOTAL $33,571,520.94 $15,621,813.92 $49,193,334.87 
 
 
From the above table, it is worthwhile noticing thegrand total cost, frequency 
of visits, and the grand average cost for enlisted an  officers. Here, the word ‘grand’ 
refers to the whole period of 1999-2009.  Enlisted p rsonnel are the majority and it 
comes naturally that their grand total cost and their fr quency of visits are much 
higher than officers. But when it comes to the grand verage cost, the grand average 
cost of officers is surprisingly higher than for enlisted. This means that the cost of 
hospitalization for an officer is higher than for an enlisted and since cost depends on 
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the kind of the disease and not on the pay rank, officers might be hospitalized for 
more “expensive” diseases, meaning that high-cost diseases are more prevalent among 
officers than enlisted. Figures 25 and 26 give a visual presentation of the grand total 
and the average cost of enlisted and officers.  
 
Figure 25: Grand Total Cost for each Pay Rank 
 
 
Figure 26: Grand Average Cost for each Pay Rank 
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Regression Analysis 
 Data Set 1 – Cost Range $0.00 - $600.00 – Model 1  
 As mentioned in Chapter III, the initial cost data set used for the Regression 
Analysis was divided into five subsets with different cost range. The first model, built 
in this part of the Regression Analysis, covers the cost range of $0.00 to $600.00.  The 
Actual by Predicted Plot, the Summary of Fit, the Analysis of Variance (ANOVA) 
and the Parameter Estimates Report of this model are given in Figure 27.  
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Actual by Predicted Plot 
 
 
Summary of Fit 
  
RSquare 0.05878 
RSquare Adj 0.058329 
Root Mean Square Error 160.6838 
Mean of Response 207.9587 
Observations (or Sum Wgts) 18819 
 
Analysis of Variance 
Source  DF Sum of Squares  Mean Square  F Ratio  
Model 9 30328082 3369787 130.5144 
Error 18809 485634728 25819 Prob > F  
C. Total 18818 515962809  <.0001* 
 
Parameter Estimates Report 
Term  Estimate  Std Error  t-ratio  Prob>|t|  VIF 
Intercept  299.06179 3.444336 86.83 0.0000* . 
AGE 45-60  -12.00913 2.838979 -4.23 <.0001* 1.1378766 
ENLISTED  -102.9175 3.440053 -29.92 <.0001* 1.9634411 
O1,O2,O3  -107.1333 6.055061 -17.69 <.0001* 1.3153296 
DUMMY FOR DISEASE 1  -12.3346 2.50661 -4.92 <.0001* 1.1141692 
DUMMY FOR DISEASE 4  62.903319 8.005478 7.86 <.0001* 1.0239846 
DUMMY FOR DISEASE 7  47.597783 9.477384 5.02 <.0001* 1.0169059 
DUMMY FOR DISEASE 10  37.920519 5.832891 6.50 <.0001* 1.0430684 
O4,O5,O6  -94.54707 4.402874 -21.47 <.0001* 1.8204513 
CD,OCS  36.904421 18.39044 2.01 0.0448* 1.0304815 
 
Figure 27: Actual by Predicted Plot, Summary of Fit, Analysis of Variance and 
Parameter Estimates for Cost range $0.00-$600.00 
 
 
 In this first model, the most predictive variables for cost, with the lowest p-
values of the t-statistic test, appear to be the following ones: AGE 45-60, ENLISTED, 
O1-O2-O3, O4-O5-O6, CD-OCS and the dummy variables for diseases 1, 4, 7 and 10.  
95 
All the variables were explained in Chapter III excpt for the dummy variables of the 
diseases. The most predictive diseases in this model are the following ones: disease 1 
refers to Ischemic Heart Disease, disease 4 refers to Malignant Neoplasms of Lip, 
Oral, Cavity and Pharyx, disease 7 refers to Malignnt Neoplasms of Urinary Bladder 
and disease 10 corresponds to Other Arterial Disease. The OLS regression model for 
the subset of $0.00 - $600.00 is given by the formula below:  
 
Cost = 299.06-12.01*(AGE 45-60)-102.92*(ENLISTED)-107.13*(O1,O2,O3)-
12.33*(Ischemic Heart Disease)+62.90*(Malignant Neoplasms of Lip, Oral, Cavity, 
Pharyx)+47.60*(Malignant Neoplasms of Urinary Bladder)+37.92*(Other Arterial 
Disease)-94.55*(O4,O5,O6)+36.90*(CD, OCS) 
 
All the Variation Inflation Factors (VIF scores) ofthis model, which measure 
the redundancy among the explanatory variables, are below 5, meaning that no 
multicollinearity occurs.  The p-value of F -statistic, which measures the overall 
model statistical significance, is shown in the Analysis of Variance in the Prob>F 
column.  In this model, the p-value of F-statistic, for a 95% confidence level, is lower 
than 0.05 and indicates a statistically significant model. Both R2 and Adjusted R2 are 
presented in the Summary of Fit, and are values that me sure the model performance. 
In this model both values are almost the same and equal to 0.058, indicating that this 
model explains approximately 5.8% of the variation in the dependent variable, which 
in this case is the cost of hospitalization. The particular low R2 value and subsequently 
the low predictability of the model, indicate that the model does not provide a good fit 
of variables with the data and there is lot of variabil ty not explained by the model.  
96 
 The Cook’s Distance Overlay plot in Figure 28 shows that there are no 
influential points.  
 
Figure 28: Overlay Plot of Cook’s Distance for Model 1  
 
The diagnostic test for Normality is the Shapiro-Wilk test, which demands a 
distribution of the studentized residuals. In the case of Shapiro-Wilk test, a p-value 
larger than 0.05 fails to reject the null hypothesis that the residuals are normally 
distributed.  In this model the Shapiro Wilk test and the distribution of studentized 
residuals are given in Figure 29.  The p-value is 0.01, lower than 0.05, and that means 
that the null hypothesis that the residuals are normally distributed is rejected, and the 
model does not pass the test for normality.              
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Fitted Normal 
Parameter Estimates 
Type  Parameter  Estimate  Lower 95%  Upper 95%  
Location µ -2.563e-7 -0.014289 0.0142884 
Dispersion σ 1.0000346 0.9900331 1.0102416 
 
 
Goodness-of-Fit Test 
KSL Test 
 
D   Prob>D  
0.107328   < 0.0100* 
 
Figure 29: Shapiro-Wilk Test for Normality for Mode l 1 
 
The test for constant variance is the Breusch-Pagan test, and tests if the 
variance of the errors is constant across the observations. In the Breusch-Pagan test, 
the null hypothesis is that the residuals exhibit constant variance and a p-value larger 
than 0.05 fails to reject the null hypothesis. This model fails to pass the Breusch-
Pagan, since the p-value is very low, lower than 0.05 and thus the null hypothesis is 
rejected. The results of the Breusch-Pagan test were calculated with the aid of 
Microsoft Excel and are given in Table 25.  
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                                  Table 25: Breusch-Pagan test for Model 1 
Input 
SSR 6.222E+10 Test Stat 46.71536 
SSE 485634728 P-value 4.43E-07 
N 18819 
df (reg) 9 
 
Data Set 2 – Cost Range $600.01 - $1,800.00 – Model 2 
In Model 1 there was a lot of variability not explained by the data and for this 
reason the model demonstrated low predictability, even though the predictive 
variables had low t-statistic p-values, and the overall p-value of the F-statistic of the 
model was low, too. The same occurs with Model 2, which regards the cost range of 
$600.01 - $1800.00.  The Summary of Fit, the Analysis of Variance, and the 
Parameter Estimates report of Model 2 are given in Figure 30.  
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Summary of Fit 
   
RSquare 0.027174 
RSquare Adj 0.025323 
Root Mean Square Error 293.2935 
Mean of Response 994.4549 
Observations (or Sum Wgts) 5791 
 
Analysis of Variance 
Source  DF Sum of Squares  Mean Square  F Ratio  
Model 11 13886220 1262384 14.6753 
Error 5779 497115830 86021 Prob > F  
C. Total 5790 511002049  <.0001* 
 
Parameter Estimates 
Term  Estimate  Std Error  t-ratio  Prob>|t|  VIF 
Intercept  924.52264 18.2785 50.58 0.0000* . 
ENLISTED  102.28975 12.37734 8.26 <.0001* 2.393883 
O1,O2,O3  107.45701 19.77797 5.43 <.0001* 1.3301553 
O4,O5,O6  69.116268 14.08404 4.91 <.0001* 1.9318035 
DUMMY FOR DISEASE 1  -39.79508 13.49212 -2.95 0.0032* 3.0627137 
DUMMY FOR DISEASE 10  -115.4091 29.61618 -3.90 <.0001* 1.1884551 
DUMMY FOR DISEASE 2  -41.32374 14.14094 -2.92 0.0035* 2.8695385 
DUMMY FOR DISEASE 8  -153.7974 25.99338 -5.92 <.0001* 1.2590722 
E5,E6  22.610802 9.804203 2.31 0.0211* 1.2787366 
DUMMY FOR DISEASE 11  -74.36178 20.83754 -3.57 0.0004* 1.4674738 
GENDER_1  27.247629 11.44658 2.38 0.0173* 1.0622896 
O7,O8,O9,O10  163.22885 62.16223 2.63 0.0087* 1.0290769 
 
 
Figure 30: Summary of Fit, Analysis of Variance and Parameter Estimates for 
Cost range $600.01-$1800.00 
 
This model appears to have even lower predictability than Model 1. The R2 
value equals to 0.0272, and this means that the model explains approximately 2.72% 
of the variation in the dependent variable.  The ovrall p-value of the F-statistic is 
lower than 0.05 and thus the null hypothesis that te explanatory variables in the 
model are not effective is rejected. The predictive variables of this model with low t-
statistic p-values are: ENLISTED, O1-O2-O3, O4-O5-O6, 7-O8-O9-O10, E5-E6, 
GENDER_1 and the Dummy Variables for Diseases 1, 2,8 10 and 11. Disease 1 
refers to Ischemic Heart Disease, disease 2 refers to Cerebrovascular disease, disease 
8 refers to Bronchitis, Emphysema, disease 10 refers to Other Arterial disease and 
disease 11 refers to the rest of the most prevalent diseases related to smoking, which 
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are presented in a detailed way in Table 15. The OLS regression model for the cost 
range of $600.01 - $1800.00 is given by the formula below:  
 
Cost=924.52+102.29*(ENLISTED)+107.46*(O1,O2,O3)+69.12*(O4,O5,O6)
+ 163.23*(O7,O8,O9,O10)+22.61*(E5,E6)+27.25*(GENDER_1)-
39.80*(Ischemic Heart Disease)-41.32*(Celebrovascular Disease)-
153.80*(Bronchitis, Emphysema)-115.41*(Other Arterial disease)-
74.36*(Other Diseases)  
 
The VIF scores of all the variables are below 5 and the model does not have 
any influential points, as shown in Cook’s Distance Overlay Plot in Appendix C. In 
addition, the model does not pass the Shapiro-Wilk test for normality and the 
Breusch-Pagan test for constant variance.   
Data Set 3 – Cost Range $1,800.01 - $11,000.00 – Model 3 
The third model concerns the data set of cost range $1800.01-$11,000.00 and 
the Summary of Fit, the Analysis of Variance, and the Parameter Estimates report are 
given below in Figure 31.  
 
 
 
 
 
 
 
 
101 
Summary of Fit 
   
RSquare 0.008385 
RSquare Adj 0.007316 
Root Mean Square Error 2443.441 
Mean of Response 4578.227 
Observations (or Sum Wgts) 2785 
 
 
 
Analysis of Variance 
Source  DF Sum of Squares  Mean Square  F Ratio  
Model 3 140406398 46802133 7.8390 
Error 2781 1.6604e+10 5970403.4 Prob > F  
C. Total 2784 1.6744e+10  <.0001* 
 
 
 
Parameter Estimates Report 
Term  Estimate  Std Error  t-ratio  Prob>|t|  VIF 
Intercept  4835.6026 83.45806 57.94 <.0001* . 
AGE 25-34  -300.8502 134.2686 -2.24 0.0251* 1.0018253 
ENLISTED  -281.2203 98.99104 -2.84 0.0045* 1.0066894 
DUMMY FOR DISEASE 7  -951.7804 281.3771 -3.38 0.0007* 1.0053827 
 
Figure 31: Summary of Fit, Analysis of Variance and Parameter Estimates for 
Cost range $1,800.01-$11,000.00 
 
 
 This model appears to have the lowest R-Squared and Adjusted R-Squared 
values, which means that the predictability of the model is very low. The R-Square 
equals to 0.008385, indicating that this model explains approximately 0.8385% of the 
variation in the dependent variable. This occurs because there is a lot of variability in 
the data, not explained by the model.  The p-value of the F-statistic, which determines 
the overall statistical significance of the model, is very low. The p-values of the t-
statistic of each explanatory variable are lower than 0.05 and the VIF scores of all of 
them are lower than 5. The most predictive variables for this cost range are: AGE 25-
34, ENLISTED and the Dummy Variable for disease 7, which is the Malignant 
Neoplasms of Urinary Bladder. The equation of this model is given by the following 
formula:  
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Cost=4835.60-300.85*(AGE 25-34)-281.22*(ENLISTED)-951.78*(Malignant 
Neoplasms of Urinary Bladder) 
 
The model does not appear to have any influential points, according to Cook’s 
Distance Overlay plot, graphed in Appendix C. This model, like the previous ones, 
does not pass the tests for Normality and Constant V riance.  
 
Data Set 4 – Cost Range $11,000.01 - $30,000.00 – Model 4 
Model 4 regards the cost range of $11,000.01-$30,000.0  and the results of the 
Summary of Fit, the Analysis of Variance, and the Parameter Estimates Report, are 
presented below in Figure 32.  
 
Summary of Fit 
   
RSquare 0.013927 
RSquare Adj 0.011433 
Root Mean Square Error 4978.371 
Mean of Response 17518.16 
Observations (or Sum Wgts) 794 
 
 
Analysis of Variance 
Source  DF Sum of Squares  Mean Square  F Ratio  
Model 2 276876512 138438256 5.5858 
Error 791 1.9604e+10 24784176 Prob > F  
C. Total 793 1.9881e+10  0.0039* 
 
 
Parameter Estimates 
Term  Estimate  Std Error  t-ratio  Prob>|t|  VIF 
Intercept  17958.049 259.8688 69.10 <.0001* . 
O7,O8,O9,O10  6105.6255 2885.988 2.12 0.0347* 1.0043652 
AGE 35-44  -866.9508 354.9437 -2.44 0.0148* 1.0043652 
 
Figure 32: Summary of Fit, Analysis of Variance and Parameter Estimates for 
Cost range $11,000.01-$30,000.00 
 
The R2 value of this model equals 0.013927, indicating that e predictability 
of the model equals 1.3927%.  The F-statistic appears to have a p-value lower than 
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0.05 and the cost in this model is predicted by two variables, which are O7-O8-O9-
O10 and AGE 35-44.  The VIF scores of the regressors are below 5. The model is 
given by the following equation:  
 
Cost=17958.05+6105.63*(O7-O8-O9-O10)-866.95*(AGE 35-44) 
 
The Cook’s Distance Overlay plot, presented in Appendix B, does not graph 
any influential points, but the model does not pass the tests for Normality and 
Constant Variance.  
 
Data Set 5 – Cost Range $30,000.01 - $307,064.00 – Model 5 
The last model concerns the extremely high cost range of $30,000.01-
$307,064.00 and its Actual by Predicted plot, Summary of Fit, Analysis of Variance, 
and Parameter Estimates Report are given in Figure 33.  
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Actual by Predicted Plot 
 
 
Summary of Fit 
   
RSquare 0.175222 
RSquare Adj 0.164273 
Root Mean Square Error 32535.54 
Mean of Response 55917.78 
Observations (or Sum Wgts) 230 
 
 
Analysis of Variance 
Source  DF Sum of Squares  Mean Square  F Ratio  
Model 3 5.0825e+10 1.694e+10 16.0044 
Error 226 2.3923e+11 1.0586e+9 Prob > F  
C. Total 229 2.9006e+11  <.0001* 
 
 
Parameter Estimates 
Term  Estimate  Std Error  t-ratio  Prob>|t|  VIF 
Intercept  39587.422 3381.55 11.71 <.0001* . 
E1,E2,E3,E4  18783.413 7431.762 2.53 0.0122* 1.0800354 
AGE 45-60  14670.658 4695.764 3.12 0.0020* 1.0930497 
DUMMY FOR DISEASE 2  27735.602 4669.303 5.94 <.0001* 1.0549758 
 
Figure 33: Actual by Predicted Plot, Summary of Fit, Analysis of Variance and 
Parameter Estimates for Cost range $30,000.01-$307,64.00 
 
 
Compared to the previous four models, this model is the one, with the highest 
R2 and Adjusted R2 values. The R2 value equals 0.175222, which means the model 
explains 17.5222% of the variation in the dependent variable. The p-value of the F-
statistic is very low and lower than 0.05 and all the predictive variables have p-values 
of the t-statistic lower than 0.05 and VIF scores blow 5.  The regressors of this model 
are: E1-E2-E3-E4, AGE 45-60 and the Dummy Variable for disease 2, which is 
Cerebrovascular Disease. The equation of the model is the following:  
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Cost=39587.42+18783.41*(E1,E2,E3,E4)+14670.66*(AGE 45-
60)+27735.60*(Celebrovascular Disease) 
 
The Actual by Predicted Plot (See Figure 33) shows two potential influential points 
and the same can be seen from the Cook’s Distance Overlay Plot, given below in 
Figure 34.  
 
Figure 34: Cook’s Distance Overlay Plot for Model 5 
 
These two influential points correspond to the two extreme cost values of 
$252,301 and $307,063, which lie far enough from the rest of the values of this cost 
range.  Subsequently, these two values must be removed and the model must be re-
assessed and re-examined for its validity and predictability, excluding these two 
influential points. The Actual by Predicted Plot, the Summary of Fit, the Analysis of 
Variance, and the Parameter Estimates Report of the new re-assessed model are given 
in Figure 35.  
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Actual by Predicted Plot 
 
Summary of Fit 
   
RSquare 0.171248 
RSquare Adj 0.160148 
Root Mean Square Error 26341.24 
Mean of Response 53954.94 
Observations (or Sum Wgts) 228 
 
 
Analysis of Variance 
Source  DF Sum of Squares  Mean Square  F Ratio  
Model 3 3.2116e+10 1.071e+10 15.4286 
Error 224 1.5542e+11 693861153 Prob > F  
C. Total 227 1.8754e+11  <.0001* 
 
 
Parameter Estimates 
Term  Estimate  Std Error  t-ratio  Prob>|t|  VIF 
Intercept  42114.882 2747.569 15.33 <.0001* . 
E1,E2,E3,E4  20085.721 6018.051 3.34 0.0010* 1.0794089 
DUMMY FOR DISEASE 2  20959.856 3831.182 5.47 <.0001* 1.0646598 
AGE 45-60  8424.9607 3844.763 2.19 0.0295* 1.0998795 
 
Figure 35: Actual by Predicted Plot, Summary of Fit, Analysis of Variance and 
Parameter Estimates, excluding the Influential Points  
 
 The new model, excluding the influential points, has not changed that much. 
Its predictability, according to the R2 value, is 17.1248% and the p-values of the F and 
the t-statistic remain lower than 0.05. The VIF scores of the regressors are below 5. 
The new model does not pass the Shapiro-Wilk test of Normality.  The results of this 
test are presented in Figure 36.  
 
107 
Studentized Residuals COST 
 
Parameter Estimates 
Type  Parameter  Estimate  Lower 95%  Upper 95%  
Location µ -8.119e-5 -0.131208 0.1310453 
Dispersion σ 1.0048196 0.9202783 1.1065984 
 
-2log(Likelihood) = 648.228417495289 
 
Goodness-of-Fit Test 
Shapiro-Wilk W Test 
 
W   Prob<W  
0.887470   <.0001* 
 
Figure 36: Shapiro-Wilk Test for Normality for the re-assessed model  
The model does not pass the Breusch-Pagan test either. T e results of the Breusch-
Pagan test are given by Table 26. 
 
Table 26: Breusch-Pagan test for the re-assessed model  
Input 
SSR 
5.02E+1
9 
Test 
Stat 54.00829 
SSE 
1.55E+1
1 P-value 1.12E-11 
N 228 
df 
(reg) 3 
 
 The re-assessed model, excluding the two influential points, explains almost 
the same variation of the dependent variable as model 5 oes. Even though this last 
model yields the highest predictability, compared to the other four, it still cannot be 
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used to predict and explain the variation of cost, since there is a lot of variability in 
the data left unexplained. Notwithstanding, all themodels developed above, provide 
valuable information about which factors could affect the cost of hospitalization.  
Summary  
 This chapter presented the results of the Contingency Analysis, the Pivot 
Table Analysis, and the Regression Analysis. The Contingency Analysis proved the 
existence of relationship between smoking and pay rank, gender and age. 
Furthermore, it enriched this study with graphs andinformative percentages of the 
smoking status of each group of smokers, among the ADAF personnel. The Pivot 
Table Analysis focused on the cost of hospitalization of the ADAF members because 
of smoking related diseases, and provided meticulous information about the total and 
average cost of hospitalization for each year and for several groups with different 
socio-demographic characteristics. Finally, the same data set of cost was used, in 
 order to explore the statistical relationship between cost and several variables related 
to socio-demographic characteristics of the ADAF population and to the most  
prevalent diseases related to smoking. 
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 V.  Conclusions 
Overview 
 This chapter uses the results of Chapter IV to answer the research questions 
initially proposed in Chapter I.  After the assessment of the questions, an appraisal of 
the strengths and limitations of this study will be pr sented. This chapter closes with 
possible follow-up suggestions for further analysis in future studies.  
Findings  
 In Chapter I, three research questions were defined, with research question 
number one was partitioned in three sub questions. After accomplishing a literature 
review and defining the methodology used in this study, two data sets were used with 
different tools, in order to analyze and answer the res arch questions, which are the 
object of this study research. The answers of all the research questions were based on 
the results of the previous chapter.  
 Research Question 1: How is smoking affected by the socio-demographic 
characteristics of the ADAF population?  
• How smoking is affected by pay rank?  
• How smoking is affected by gender?  
• How smoking is affected by age?  
This research question was answered after the analysis of the Web HA data 
set, with the aid of the Contingency Analysis tool.  The Mosaic Plots, the 
Contingency Tables, and the Tests Reports were the products of the Contingency 
Analysis and demonstrated visually and statistically the existence of a relationship 
between smoking and pay rank, gender, and age. The Tests Reports of all three 
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Contingency Analyses developed in Chapter IV each reported very low Likelihood 
Ratio and Pearson p-values, which indicate a relationship between smoking and the 
socio-demographic characteristics of pay rank, gender, and age. Furthermore, the 
percentages of the contingency tables were used in Microsoft Excel® for a visual 
portrayal of the smoking status of Air Force, based on pay rank, gender and age.  
More specifically, regarding the subquestion ‘How is smoking affected by pay 
rank’, the analysis showed that the majority of smokers among the ADAF personnel 
consists of enlisted personnel.  First, the Contingency Analysis demonstrated that 
48.64% of the whole Air Force population smokes, which is a remarkably high 
percentage. This percentage is the result of the Contingency Analysis done with the 
usage of the AF Web HA data set. The percentage of 48.64% regards the active duty 
personnel that have used any kind of tobacco products in their entire life. That means 
that 48.64% of the active duty personnel have smoked at least 100 cigarettes or used 
any other type of tobacco product at least 20 times in their entire life. Second, 
according to the previously stated information that t e majority of smokers are 
enlisted, 48.64% of smokers, analyzed further, is comprised of 42.46% of enlisted and 
6.17% of officers. Lastly, 52.41% of the enlisted population is smokers, which 
suggests negative consequences for the quality and re diness of this population.  
There are more males in the Air Force than females nd this fact helps answer 
the subquestion “How is smoking affected by gender”. The percentage of 48.64% of 
smokers, if partitioned further under the criteria of gender, is comprised of 40.84% 
male and 7.79% female smokers. Additionally, if smokers are considered a population 
of their own, this population consists of 83.98% men and 16.02% women,  and this 
fact underscores the prevalence of smoking among men in the Air Force.  
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The final subquestion of the first research question examines the relationship 
between smoking and age. It is shown in this research that almost every age group is 
nearly equally divided into two groups:  smokers and non-smokers.  In some age 
groups smokers are the majority, such as in the age groups 17-24 and 25-29.  If the 
percentage 48.64% is broken up into age groups, the 13.94% belongs to the age group 
17-24, 12.08% to the age group 25-29 (among these two age groups, smoking is most 
prevalent), 7.85% to the age group 30-34, 6.59% to the age group 36-39, and 8.18% to 
the group over 40.  
All the above results which correlate smoking with pay rank, gender and age, 
should be used to better target smoking cessation programs and policies. The answer 
to the first research question verifies that smoking is more prevalent among the 
enlisted, males, and the young age groups. Half the enlisted population smokes. 83% 
of the smoking population is males. The age groups of 17-24 and 25-29 are the groups 
that smoke more.  
Research Question 2: Which diseases cost more to the U.S. Air Force, 
according to their total cost of hospitalization?  
The second research question was answered through the analysis of a different 
set of data than that of the first question. For the second research question, the data set 
of the cost of hospitalization of ADAF personnel because of smoking related diseases 
was used and analyzed with the assistance of Microsoft Excel, and particularly with 
the Pivot Tables tool. The most important product of this analysis was the list with the 
most prevalent diseases related to smoking with the highest cost. This list is given 
below in Table 27.  
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Table 27: List of the Most Prevalent Diseases Related to Smoking 
with the Highest Cost 
ISCHEMIC HEART DISEASE 1 
CEREBROVASCULAR DISEASE 2 
MALIGNANT NEOPLASMS OF TRACHEA, LUNG, BRONCHUS 3 
MALIGNANT NEOPLASMS OF LIP, ORAL, CAVITY, PHARYX 4 
OTHER HEART DISEASE 5 
MALIGNANT NEOPLASMS OF KIDNEY AND RENAL PELVIS 6 
MALIGNANT NEOPLASMS OF URINARY BLADDER 7 
BRONCHITIS, EMPHYSEMA 8 
MALIGNANT NEOPLASMS OF PANCREAS 9 
OTHER ARTERIAL DISEASE 10 
OTHERS 11 
 
The above table helps answer the second research question, but the 
manipulation of the data, in the process of answering the second research question, 
produced numerous results and outcomes. The Pivot Tables showed that the grand 
total cost of hospitalization for the period 1999-2009 was $49,193,334, where 
$43,013,308 concerned the male population of the Air Force and $6,180,026 the 
female population of the Air Force. Furthermore, the grand average cost (the 
definition “grand” refers to the period 1999-2009) for males was $1,774 and for 
females $1,480, indicating that the gap of average cost for both genders is not large 
and cost might not be affected by gender.  Of importance is that the age groups with 
the highest grand total cost were the groups of 33-40 and 41-48 years. In addition, the 
groups with the highest grand average cost were the age groups 41-48, 49-56, and 57-
64 years old.  Supplementary information to the statistical analysis, regarding the age 
groups, is that groups 33-40 and 41-48 years old were the groups with the highest 
grand total number of visits to hospital or doctor. All this information, combined with 
the previous Contingency Analysis of the correlation between smoking and age, 
provides significant evidence that smoking is most prevalent among the young ages of 
17 to 29, while the cost consequences of smoking are apparent in the older age groups 
of 33 to 48. A preventive anti-smoking policy, mostly focused on the younger ages 
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when people start smoking, could reduce the number of future smokers and save a 
considerable part of the Air Force budget spent on medical expenses related to 
smoking.  
The outcome of the analysis of the frequency of visits to the hospital or to the 
doctor, due to a disease related to smoking, generated another list of diseases. In this 
list, the diseases were sorted by their frequency of appearance in the Primary 
Diagnosis column. Ischemic heart disease and cerebrovascular disease were the top 
two diseases, while being the diseases with the highest cost. This validates that these 
two diseases are the most prevalent diseases related to smoking. Finally, it is 
worthwhile to mention that the largest part of the grand total medical expenses of the 
Air Force related to smoking was due to the enlisted population. During the period 
1999-2009, $33,571,520 was spent for the hospitalization of enlisted personnel and 
$15,621,813 was spent for the hospitalization of officers. The pattern of the grand 
average cost for each pay rank is reversed, with the grand average cost of enlisted was 
$1,590 and of the officers $2,135. Additionally, the general grand average cost of 
hospitalization for the whole Air Force population was $1,731.  
The answer of the second research question revealed that the most prevalent 
diseases related to smoking are ischemic heart disease and cerebrovascular disease. 
Moreover, the largest portion of the medical expenses related to hospitalization 
corresponds to the enlisted population and the age r nge 33 to 48. Furthermore, 
smoking is most prevalent among men. All these conclusions could compose the main 
targets of a future, more effective anti-smoking camp ign and of a beneficiary 
research for the shrinkage of the medical expenses of the ADAF personnel, related to 
smoking.  
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Research Question 3: How is the cost of hospitalization affected by 
gender, age, pay rank and each disease separately?  
The third research question of this study was answered through the analysis of 
the same cost data set used in research question two. The tool used for the analysis of 
the data set and for answering the third question was the Regression Analysis, with 
the aid of JMP. Five models were developed, for five subsets of different cost range, 
in order to detect a relationship between cost and gender, age, pay rank, and the most 
prevalent diseases related to smoking with the highest cost. All five models generated 
low R2 and low Adjusted R2 values, meaning that the whole predictability of the 
models was of minimal importance.  There was a lot of variability in the data set, not 
explained by the models, and for this reason the models did not provide a good fit for 
the variables with the data.  The overall p-value of the F-statistic for all five models 
was very low, allowing the rejection of the null hypothesis that the explanatory 
variables are not effective and indicating that the explanatory variables are statistically 
related to the dependent variable.  The same result occurred with the p-values of the t-
statistic of each variable used in the models. All the variables resulted in low p-values 
and VIF scores below 5. The variables used more than one time in the five models 
developed in the Regression Analysis, are: AGE 45-60, ENLISTED, O1-O2-O3, O4-
O5-O6, O7-O8-O9-O10, Ischemic Heart Disease, Cerebrovascular Disease, Malignant 
Neoplasms of Urinary Bladder, and Other Arterial Disease. These variables have 
greater effect and better explain the cost of hospitalization.  The age that affects cost 
the most is 45- 60 years old. All the pay grades of officers explain and affect the cost 
more than the pay grades of enlisted. This might be due to the higher average cost of 
officers, shown in the Pivot Table analysis. The diseases that affect cost more are the 
diseases numbered 1, 2, 7 and 10 of the list (See Table 27) of the most prevalent 
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diseases related to smoking with the highest cost. These diseases correspond to 
Ischemic Heart Disease, Cerebrovascular Disease, Malignant Neoplasms of Urinary 
Bladder and Other Arterial Disease. The Regression Analysis proved that the two 
diseases with the highest cost and with the highest fr quency of visits, Ischemic Heart 
Disease and the Cerebrovascular Disease, are the diseases that affect cost most, and 
can be used as explanatory variables of cost.  
 
Strengths and Limitations  
 According to the research questions defined in Chapter I, this study tried to 
detect the existence of a relationship between smoking and several socio-demographic 
characteristics associated with the Air Force population, to present the status of 
smoking among the ADAF personnel, to investigate the factors that affect the cost of 
hospitalization due to smoking related diseases, and to examine which variables could 
be the most explanatory ones for the prediction of this cost. The various methods used 
for the investigation of the research questions andthe results returned from the 
analysis, showed the strengths and the limitations of this study.  
One of the strengths of this study is the fact thate Contingency Analysis 
proved the existence of a strong relationship betwen smoking and pay rank, gender 
and age. Moreover, this kind of analysis enriched the study with information and 
graphs about the smoking status of the ADAF personnel. A second strength of this 
research is for the findings regarding the assortmen  of diseases by their total cost and 
their frequency of visits during the period 1999-2009. This classification was used in 
the Regression Analysis for the creation of dummy variables, associated with the 
diseases, which were later used for the development of the OLS linear models. 
Furthermore, the Pivot Table Analysis enhanced the informative status of this study 
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about the cost of smoking, generating percentages and graphs associated with the total 
and average cost of each socio-demographic group of the U.S. Air Force.  This type of 
analysis showed that the grand total cost of enlisted was much higher than the grand 
total cost of officers, but the grand average cost of officers was higher than the grand 
average cost of enlisted.  This piece of information was confirmed later in the 
Regression Analysis, where the pay grades of officers were among the explanatory 
factors of the cost.  
The study is limited as the OLS linear models, develop d in the Regression 
Analysis, do not guarantee predictability, and likely cannot be used for future 
research. The variability, spread in the data, did not permit a good fit of the variables 
with the data. Nevertheless, the five models developed gave a number of variables 
that could be used in the future as explanatory variables of cost, in different data sets 
with lower variability. Even though the predictability of the models is very low and 
the models do not explain at a satisfactory level th  variation in the cost, the same 
models demonstrated that the variables used as explanatory variables, include 
Ischemic Heart Disease, Cerebrovascular Disease, the age group of 45-60, and the pay 
grades of officers, which are variables shown to affect the cost in the Pivot Table 
Analysis as well. Underneath the Regression Analysis of this study there is strength, 
limited by the low predictability of the models.  
 
Follow-Up Suggestions for Further Research 
Opportunities for further research include the investigation of the average cost 
of officers. The Pivot Table Analysis revealed that the grand total cost of enlisted is 
remarkably higher, compared to the cost of the officers. On the other hand, the grand 
average cost of officers seems to be noticeably higher compared to the cost of 
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enlisted. Moreover, in the Regression Analysis it was shown that, among the 
explanatory variables of the cost, there was a variable referencing enlisted and 
variables associated with all the pay grades of officers. This fact proves that enlisted 
affect the total cost, but officers affect the averge cost. The further research here lies 
in investigating the factors that influence the aver g  cost of officers and render it 
higher compared to the one of enlisted.  
Other research efforts should be directed at comparing the results of this study 
with analogous studies, elaborated in the other armed forces of the U.S. military. 
Identifying differences in the explanatory factors f cost and in the classification of 
the most prevalent diseases related to smoking with the rest of the armed forces, could 
grant a better and more scrupulous portrait of the smoking status of the Air Force.  
Summary  
Smoking is a social phenomenon and nowadays is chara terized as an 
epidemic. It likely affects people of every race and social status. Smoking has become 
an alarming issue for the U.S. Air Force since, as demonstrated in this study, almost 
half the population of the ADAF personnel smokes. This study examined the 
association of smoking status and cost, provoked by smoking, with several socio-
demographic characteristics of the Air Force population. These results could be used 
in the future, for a more effective and focused on specific groups, smoking cessation 
campaign and policy, for eliminating the smoking phenomenon and improving the 
quality of health, productivity, and readiness of the U.S. Air Force personnel.  
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Appendix A. AF Web  HA Data Dictionary – Tobacco-Use section  
SECTION 8: TOBACCO USE 
 
Q8_1a    Type: Numeric    Qcode: T1 
 
Section Number: 8-Tobacco Use Question: In your entire life, have you? 
(Check all that apply) Smoked at least 
one hundred cigarettes?   
 
Description:  Derived from question: “In your entire life, have you? (Check 
all that apply)” Smoked at least one hundred cigarettes? 
 
Value:  Description: 
1   Checked - Smoked at least one hundred cigarettes? 
 
 
Q8_1b    Type: Numeric    Qcode: T1 
 
Section Number: 8-Tobacco Use Question: In your entire life, have you? 
(Check all that apply) Smoked a pipe at 
least 20 times?   
 
Description:  Derived from question: “In your entire life, have you? (Check 
all that apply)” Smoked a pipe at least 20 times? 
 
Value:  Description: 
1 Checked - Smoked a pipe at least 20 times? 
 
 
Q8_1c    Type: Numeric    Qcode: T1 
 
Section Number: 8-Tobacco Use Question: In your entire life, have you? 
(Check all that apply) Smoked a cigar at 
least 20 times?   
 
Description:  Derived from question: “In your entire life, have you? (Check 
all that apply)” Smoked a cigar at least 20 times? 
 
Value:  Description: 
1 Checked - Smoked a cigar at least 20 times? 
 
 
Q8_1d    Type: Numeric    Qcode: T1 
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Section Number: 8-Tobacco Use Question: In your entire life, have you? 
(Check all that apply) Used chewing 
tobacco or snuff at least 20 times?   
 
Description:  Derived from question: “In your entire life, have you? (Check 
all that apply)” Used chewing tobacco or snuff at least 20 
times? 
 
Value:  Description: 
1 Checked - Used chewing tobacco or snuff at least 20 times? 
 
 
Q8_1e    Type: Numeric    Qcode: T1 
 
Section Number: 8-Tobacco Use Question: In your entire life, have you? 
(Check all that apply) I only use tobacco 
products occasionally   
 
Description:  Derived from question: “In your entire life, have you? (Check 
all that apply)”  I only use tobacco products occasionally 
 
Value:  Description: 
1 Checked - I only use tobacco products occasionally 
 
 
Q8_1f    Type: Numeric    Qcode: T1 
 
Section Number: 8-Tobacco Use Question: In your entire life, have you? 
(Check all that apply) I have never used 
tobacco products   
 
Description:  Derived from question: “In your entire life, have you? (Check 
all that apply)” I have never used tobacco products 
 
Value:  Description: 
1 Checked - I have never used tobacco products 
 
 
Q8_2a    Type: Numeric    Qcode: T2 
 
Section Number: 8-Tobacco Use Question: Do you currently use any of 
the following tobacco products? (Check 
all that apply) Cigarettes 
 
Description:  Derived from question: “Do you currently use any of the 
following tobacco products? (Check all that apply)” Cigarettes. 
(Asked if Q8_1f  NE 1). 
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Value:  Description: 
1 Checked - Cigarettes 
 
 
Q8_2b    Type: Numeric    Qcode: T2 
 
Section Number: 8-Tobacco Use Question: Do you currently use any of 
the following tobacco products? (Check 
all that apply) Pipe 
 
Description:  Derived from question: “Do you currently use any of the 
following tobacco products? (Check all that apply)” Pipe. 
(Asked if Q8_1f  NE 1). 
 
Value:  Description: 
1 Checked - Pipe 
 
 
Q8_2c    Type: Numeric    Qcode: T2 
 
Section Number: 8-Tobacco Use Question: Do you currently use any of 
the following tobacco products? (Check 
all that apply) Cigars 
 
Description:  Derived from question: “Do you currently use any of the 
following tobacco products? (Check all that apply)” Cigars. 
(Asked if Q8_1f  NE 1). 
 
Value:  Description: 
1 Checked - Cigars 
 
 
Q8_2d    Type: Numeric    Qcode: T2 
 
Section Number: 8-Tobacco Use Question: Do you currently use any of 
the following tobacco products? (Check 
all that apply) Chewing tobacco or snuff 
 
Description:  Derived from question: “Do you currently use any of the 
following tobacco products? (Check all that apply)” Chewing 
tobacco or snuff. (Asked if Q8_1f  NE 1). 
 
Value:  Description: 
1 Checked - Chewing tobacco or snuff 
 
 
Q8_2e    Type: Numeric    Qcode: T2 
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Section Number: 8-Tobacco Use Question: Do you currently use any of 
the following tobacco products? (Check 
all that apply) None of the above 
 
Description:  Derived from question: “Do you currently use any of the 
following tobacco products? (Check all that apply)” None of 
the above. (Asked if Q8_1f  NE 1). 
 
Value:  Description: 
1 Checked - None of the above 
 
 
Q8_3    Type: Numeric    Qcode: T3a 
 
Section Number: 8-Tobacco Use Question: Do you now smoke 
cigarettes? 
 
Description:  Response to question: “Do you now smoke cigarettes?” (Asked 
if Q8_2a  = 1). 
 
Value:  Description: 
1 Smoke cigarettes every day 
2 Smoke cigarettes on some days 
 
 
Q8_4    Type: Numeric    Qcode: T7 
 
Section Number: 8-Tobacco Use Question: About how long ago was it 
that you started smoking cigarettes? 
 
Description:  Response to question: “About how long ago was it tha  you 
started smoking cigarettes?” (Asked if Q8_3  = 1). 
 
Value:  Description: 
1 Less than 1 month ago 
2 1 month but less than 3 months ago 
3 3 months but less than 6 months ago 
4 6 months but less than 12 months ago 
5 1 year but less than 5 years ago 
6 More than 5 years ago 
9 Don't know / Not sure 
 
 
Q8_5    Type: Numeric    Qcode: T8 
 
Section Number: 8-Tobacco Use Question: All together, for how many 
years have you been a regular smoker, 
not including the years that you had quit? 
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Description:  Response to question: “All together, for how many years have 
you been a regular smoker, not including the years that you had 
quit?” (Asked if Q8_4  = 5 or 6). 
 
Value:  Description: 
1 1-2 years 
2 3-5 years 
3 6-10 years 
4 11-15 years 
5 16-20 years 
6 More than 20 years 
9 Don't know / Not sure 
 
 
Q8_6    Type: Numeric    Qcode: T9 
 
Section Number: 8-Tobacco Use Question: On the average, how many 
cigarettes do you now smoke per day? 
 
Description:  Response to question: “On the average, how many cigarettes do 
you now smoke per day?” (Asked if Q8_3  = 1). 
 
Value:  Description: 
1 Less than 1 cigarette a day 
2 1-10 cigarettes a day (half a pack) 
3 11-20 cigarettes a day (1 pack) 
4 21-30 cigarettes a day (1 and a half packs) 
5 31-40 cigarettes a day (2 packs) 
6 More than 40 cigarettes a day (more than 2 packs) 
9 Don't know / Not sure 
 
 
Q8_7    Type: Numeric    Qcode: T10 
 
Section Number: 8-Tobacco Use Question: Which best describes your 
intentions regarding quitting smoking? 
 
Description:  Response to question: “Which best describes yourintentions 
regarding quitting smoking?” (Asked if Q8_3  = 1). 
 
Value:  Description: 
1 I intend to quit in the next 30 days and have trid for at least 24 
hours in the past year 
2 I intend to quit in the next 30 days 
3 I intend to quit  in the next 6 months 
4 I do not intend to quit in the next 6 months 
 
 
Q8_8    Type: Numeric    Qcode: T11 
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Section Number: 8-Tobacco Use Question: About how long ago was it 
that you started smoking cigarettes? 
 
Description:  Response to question: “About how long ago was it tha  you 
started smoking cigarettes?” (Asked if Q8_3  = 2). 
 
Value:  Description: 
1 Less than 1 month ago 
2 1 month but less than 3 months ago 
3 3 months but less than 6 months ago 
4 6 months but less than 12 months ago 
5 1 year but less than 5 years ago 
6 More than 5 years ago 
9 Don't know / Not sure 
 
 
Q8_9    Type: Numeric    Qcode: T12 
 
Section Number: 8-Tobacco Use Question: All together, for how many 
years have you smoked cigarettes, not 
including the years that you have quit? 
 
Description:  Response to question: “All together, for how many years have 
you smoked cigarettes, not including the years that you have 
quit?” (Asked if Q8_8  = 5 or 6). 
 
Value:  Description: 
1 1-2 years 
2 3-5 years 
3 6-10 years 
4 11-15 years 
5 16-20 years 
6 More than 20 years 
9 Don't know / Not sure 
 
 
Q8_10    Type: Numeric    Qcode: T13 
 
Section Number: 8-Tobacco Use Question: On the average, when you 
smoked during the past 30 days, about 
how many cigarettes did you smoke each 
day? 
 
Description:  Response to question: “On the average, when you smoked 
during the past 30 days, about how many cigarettes did you 
smoke each day?” (Asked if Q8_3  = 2). 
 
Value:  Description: 
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1 Less than 1 cigarette a day 
2 1-10 cigarettes a day (half a pack) 
3 11-20 cigarettes a day (1 pack) 
4 21-30 cigarettes a day (1 and a half packs) 
5 31-40 cigarettes a day (2 packs) 
6 More than 40 cigarettes a day (more than 2 packs) 
9 Don't know / Not sure 
 
 
Q8_11    Type: Numeric    Qcode: T14 
 
Section Number: 8-Tobacco Use Question: On how many of the past 30 
days did you smoke cigarettes? 
 
Description:  Response to question: “On how many of the past 30 days did 
you smoke cigarettes?” (Asked if Q8_3  = 2). 
 
Value:  Description: 
1 1-5 days 
2 6-10 days 
3 11-15 days 
4 16-20 days 
5 21-25 days 
6 26-30 days 
9 Don't know / Not sure 
 
 
Q8_12    Type: Numeric    Qcode: T15 
 
Section Number: 8-Tobacco Use Question: Which best describes your 
intentions regarding quitting smoking? 
 
Description:  Response to question: “Which best describes yourintentions 
regarding quitting smoking?” (Asked if Q8_3  = 2). 
 
Value:  Description: 
1 I intend to quit in the next 30 days and have trid for at least 24 
hours in the past year 
2 I intend to quit in the next 30 days 
3 I intend to quit  in the next 6 months 
4 I do not intend to quit in the next 6 months 
 
 
Q8_13    Type: Numeric    Qcode: T3b 
 
Section Number: 8-Tobacco Use Question: Do you now smoke a pipe? 
 
Description:  Response to question: “Do you now smoke a pipe?” (Asked if 
Q8_2b  = 1). 
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Value:  Description: 
1 Smoke a pipe every day 
2 Smoke a pipe on some days 
 
 
Q8_14    Type: Numeric    Qcode: T18AF 
 
Section Number: 8-Tobacco Use Question: Which best describes your 
intentions regarding quitting smoking a 
pipe? 
 
Description:  Response to question: “Which best describes yourintentions 
regarding quitting smoking a pipe?” (Asked if Q8_2b  = 1). 
 
Value:  Description: 
1 I intend to quit in the next 30 days and have trid for at least 24 
hours in the past year 
2 I intend to quit in the next 30 days 
3 I intend to quit  in the next 6 months 
4 I do not intend to quit in the next 6 months 
 
 
Q8_15    Type: Numeric    Qcode: T3c 
 
Section Number: 8-Tobacco Use Question: Do you now smoke cigars? 
 
Description:  Response to question: “Do you now smoke cigars?” (Asked if 
Q8_2c  = 1). 
 
Value:  Description: 
1 Smoke cigars every day 
2 Smoke cigars on some days 
 
 
Q8_16    Type: Numeric    Qcode: T19af 
 
Section Number: 8-Tobacco Use Question: Which best describes your 
intentions regarding quitting smoking 
cigars? 
 
Description:  Response to question: “Which best describes yourintentions 
regarding quitting smoking cigars?” (Asked if Q8_2c  = 1). 
 
Value:  Description: 
1 I intend to quit in the next 30 days and have trid for at least 24 
hours in the past year 
2 I intend to quit in the next 30 days 
3 I intend to quit  in the next 6 months 
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4 I do not intend to quit in the next 6 months 
 
 
Q8_17    Type: Numeric    Qcode: T3d 
 
Section Number: 8-Tobacco Use Question: Do you now use chewing 
tobacco or snuff? 
 
Description:  Response to question: “Do you now use chewing tobacco or 
snuff?” (Asked if Q8_2d  = 1). 
 
Value:  Description: 
1 Use chewing tobacco or snuff every day 
2 Use chewing tobacco or snuff on some days 
 
 
Q8_18    Type: Numeric    Qcode: T16 
 
Section Number: 8-Tobacco Use Question: About how long ago was it 
that you started using chewing tobacco 
or snuff regularly? 
 
Description:  Response to question: “About how long ago was it tha  you 
started using chewing tobacco or snuff regularly?” (Asked if 
Q8_2d  = 1). 
 
Value:  Description: 
1 Less than 1 month ago 
2 1 month but less than 3 months ago 
3 3 months but less than 6 months ago 
4 6 months but less than 12 months ago 
5 1 year but less than 5 years ago 
6 More than 5 years ago 
9 Don't know / Not sure 
 
 
Q8_19    Type: Numeric    Qcode: T17 
 
Section Number: 8-Tobacco Use Question: On the average, when you 
smoked during the past 30 days, about 
how many cigarettes did you smoke each 
day? 
 
Description:  Response to question: “On the average, when you smoked 
during the past 30 days, about how many cigarettes did you 
smoke each day?” (Asked if Q8_2d  = 1). 
 
Value:  Description: 
1 Less than 1 time a day 
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2 1-2 times a day 
3 3-5 times a day 
4 6-10 times a day 
5 11-20 times a day 
6 More than 20 times a day 
9 Don't know / Not sure 
 
 
Q8_20    Type: Numeric    Qcode: T17aAF 
 
Section Number: 8-Tobacco Use Question: Which best describes your 
intentions regarding quitting smokeless 
tobacco (chewing tobacco or snuff)? 
 
Description:  Response to question: “Which best describes yourintentions 
regarding quitting smokeless tobacco (chewing tobacco or 
snuff)?” (Asked if Q8_2d  = 1). 
  
Value:  Description: 
1 I intend to quit in the next 30 days and have trid for at least 24 
hours in the past year 
2 I intend to quit in the next 30 days 
3 I intend to quit  in the next 6 months 
4 I do not intend to quit in the next 6 months 
 
 
Q8_21    Type: Numeric    Qcode: T4 
 
Section Number: 8-Tobacco Use Question: About how long has it been 
since you last smoked cigarettes? 
 
Description:  Response to question: “About how long has it been since you 
last smoked cigarettes?” (Asked if Q8_1a  = 1 and Q8_2e=1). 
  
Value:  Description: 
1 Less than 1 month ago 
2 1 month but less than 3 months ago 
3 3 months but less than 6 months ago 
4 6 months ago or more 
9 Don't know / Not sure 
 
 
Q8_22    Type: Numeric    Qcode: T5 
 
Section Number: 8-Tobacco Use Question: During the years that you 
smoked, about how many cigarettes per 
day did you smoke? 
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Description:  Response to question: “During the years that you smoked, 
about how many cigarettes per day did you smoke?” (Asked if 
Q8_1a  = 1 and Q8_2e=1). 
 
Value:  Description: 
1 Less than 1 cigarette a day 
2 1-10 cigarettes a day (half a pack) 
3 11-20 cigarettes a day (1 pack) 
4 21-30 cigarettes a day (1 and a half packs) 
5 31-40 cigarettes a day (2 packs) 
6 More than 40 cigarettes a day (more than 2 packs) 
9 Don't know / Not sure 
 
 
Q8_23    Type: Numeric    Qcode: T6 
 
Section Number: 8-Tobacco Use Question: All together, for how many 
years did you smoke cigarettes, not 
including the years that you had quit? 
 
Description:  Response to question: “All together, for how many years did 
you smoke cigarettes, not including the years that you had 
quit?” (Asked if Q8_1a  = 1 and Q8_2e=1). 
 
Value:  Description: 
1 Less than 1 year 
2 1-2 years 
3 3-5 years 
4 6-10 years 
5 11-15 years 
6 16-20 years 
7 More than 20 years 
9 Don't know / Not sure 
 
 
Q8_24    Type: Numeric    Qcode: T24AF 
 
 ADDED 10/31/2008 
 
Section Number: 8-Tobacco Use Question: During the past 12 months, 
have you stopped the use of any tobacco 
products for one day or longer because 
you were trying to quit? 
 
Description:  Response to question: “During the past 12 months, have you 
stopped the use of any tobacco products for one day or longer 
because you were trying to quit?” (Asked if Q8_1f ne 1). 
 
Value:  Description: 
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1 Yes 
2 No 
 
 
Q8_25    Type: Numeric    Qcode: T25AF 
 
 ADDED 10/31/2008 
 
Section Number: 8-Tobacco Use Question: When you last stopped the use 
of tobacco products for one day or 
longer, did you do anything to assist you 
with quitting? 
 
Description:  Response to question: “When you last stopped the use of 
tobacco products for one day or longer, did you do anything to 
assist you with quitting?” (Asked if Q8_24 = 1). 
 
Value:  Description: 
1 Yes 
2 No 
 
 
Q8_26a   Type: Numeric    Qcode: T26AF 
 
 ADDED 10/31/2008 
 
Section Number: 8-Tobacco Use Question: When you last stopped the use 
of tobacco products, what did you do to 
assist you with quitting? (Check all that 
apply) Consulted with (non-HAWC) 
Doctor, Nurse, or other health 
professional 
 
Description:  Derived from response to question: “When you last stopped the 
use of tobacco products, what did you do to assist you with 
quitting? (Check all that apply) Consulted with (non-HAWC) 
Doctor, Nurse, or other health professional” (Asked if Q8_25 = 
1). 
 
Value:  Description: 
1 Checked - Consulted with (non-HAWC) Doctor, Nurse, or 
other health professional 
 
 
Q8_26b   Type: Numeric    Qcode: T26AF 
 
 ADDED 10/31/2008 
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Section Number: 8-Tobacco Use Question: When you last stopped the use 
of tobacco products, what did you do to 
assist you with quitting? (Check all that 
apply) Medication such as nicotine gum, 
patch, nasal spray, inhaler, lozenge, or 
prescription medication 
 
Description:  Derived from response to question: “When you last stopped the 
use of tobacco products, what did you do to assist you with 
quitting? (Check all that apply) Medication such as nicotine 
gum, patch, nasal spray, inhaler, lozenge, or prescription 
medication” (Asked if Q8_25 = 1). 
 
Value:  Description: 
1 Checked - Medication such as nicotine gum, patch, nasal spray, 
inhaler, lozenge, or prescription medication 
 
 
Q8_26c   Type: Numeric    Qcode: T26AF 
 
 ADDED 10/31/2008 
 
Section Number: 8-Tobacco Use Question: When you last stopped the use 
of tobacco products, what did you do to 
assist you with quitting? (Check all that 
apply) Class 
 
Description:  Derived from response to question: “When you last stopped the 
use of tobacco products, what did you do to assist you with 
quitting? (Check all that apply) Class” (Asked if Q8_25 = 1). 
 
Value:  Description: 
1 Checked - Class 
 
 
Q8_26d   Type: Numeric    Qcode: T26AF 
 
 ADDED 10/31/2008 
 
Section Number: 8-Tobacco Use Question: When you last stopped the use 
of tobacco products, what did you do to 
assist you with quitting? (Check all that 
apply) Call-line 
 
Description:  Derived from response to question: “When you last stopped the 
use of tobacco products, what did you do to assist you with 
quitting? (Check all that apply) Call-line” (Asked if Q8_25 = 
1). 
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Value:  Description: 
1 Checked – Call-line 
 
 
Q8_26e   Type: Numeric    Qcode: T26AF 
 
 ADDED 10/31/2008 
 
Section Number: 8-Tobacco Use Question: When you last stopped the use 
of tobacco products, what did you do to 
assist you with quitting? (Check all that 
apply) One-on-one session with HAWC 
staff 
 
Description:  Derived from response to question: “When you last stopped the 
use of tobacco products, what did you do to assist you with 
quitting? (Check all that apply) One-on-one session with 
HAWC staff” (Asked if Q8_25 = 1). 
 
Value:  Description: 
1 Checked - One-on-one session with HAWC staff 
 
 
Q8_26f   Type: Numeric    Qcode: T26AF 
 
 ADDED 10/31/2008 
 
Section Number: 8-Tobacco Use Question: When you last stopped the use 
of tobacco products, what did you do to 
assist you with quitting? (Check all that 
apply) Web-based support program 
 
Description:  Derived from response to question: “When you last stopped the 
use of tobacco products, what did you do to assist you with 
quitting? (Check all that apply) Web-based support rogram” 
(Asked if Q8_25 = 1). 
 
Value:  Description: 
1 Checked - One Web-based support program 
 
 
Q8_26g   Type: Numeric    Qcode: T26AF 
 
 ADDED 10/31/2008 
 
Section Number: 8-Tobacco Use Question: When you last stopped the use 
of tobacco products, what did you do to 
assist you with quitting? (Check all that 
apply) None of the above 
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Description:  Derived from response to question: “When you last stopped the 
use of tobacco products, what did you do to assist you with 
quitting? (Check all that apply) None of the above” (Asked if 
Q8_25 = 1). 
 
Value:  Description: 
1 Checked - None of the above 
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Appendix B. Distributions of the initial data set and of the five subsets 
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Figure 37: Distribution of the Initial data set 
 
 
 
   Histogram                                                Quantiles 
 
                                                                         
Moments 
 
 
Mean 207.9587 
Std Dev 165.58556 
Std Err Mean 1.207047 
Upper 95% Mean 210.32462 
Lower 95% Mean 205.59278 
N 18819 
 
Figure 38: Distribution of Cost for the range $0 - $600.00 
 
 
    
100.0% maximum                             307063 
99.5%                               38547 
97.5%                               15031 
90.0%                                  2952 
75.0% quartile                                  879 
50.0% median                                  338 
25.0% quartile                                   103 
10.0%                                      42
2.5%                               9.3111 
0.5%                                       0
0.0% minimum                                      0 
  
Mean 1731.0016 
Std Dev 6685.8571 
Std Err Mean 39.659999 
Upper 95% Mean 1808.7371 
Lower 95% Mean 1653.2661 
N 28419 
    
100.0% maximum 599.99 
99.5%  593.95 
97.5%  559.09 
90.0%  467.69 
75.0% quartile 334.98 
50.0% median 166.99 
25.0% quartile 64.67 
10.0%  26.64 
2.5%  0.00 
0.5%  0.00 
0.0% minimum 0.00 
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Histogram                                                  Quantiles 
                                                                                        
                                                                                                            
 
 
 
 
 
 
Figure 39: Distribution of Cost for the range $600.01 - $1,800.00 
 
 
 
 
 Histogram                                                 Quantiles     
 
 
 
 
 
 
 
 
Figure 40: Distribution of cost for the range $1,80.01 – 11,000.00 
 
 
 
 
 
 
    
100.0% maximum 1799.3 
99.5%  1781.5 
97.5%  1700.6 
90.0%  1440.6 
75.0% quartile 1180.0 
50.0% median 928.9 
25.0% quartile 754.0 
10.0%  654.2 
2.5%  612.4 
0.5%  602.7 
0.0% 
 
Moments 
                                     
Mean 
Std Dev 
Std Err Mean 
Upper 95% Mean 
Lower 95% Mean 
N 
 
minimum 600.1 
 
 
                    994.45493 
                    297.07906 
                    3.9038692 
                      1002.108 
                    986.80188 
                              5791
 
    
100.0% maximum 10991.9 
99.5%  10879.4 
97.5%  10456.9 
90.0%  8548.81 
75.0% quartile 6037.71 
50.0% median 3869.56 
25.0% quartile 2551.11 
10.0%  2051.51 
2.5%  1853.76 
0.5%  1813.55 
0.0% 
 
Moments 
  
Mean 
Std Dev 
Std Err Mean 
Upper 95% Mean 
Lower 95% Mean 
N 
 
minimum 1801.03 
 
 
                    4578.2267 
                      2452.428 
                    46.471177 
                     4669.3481
                    4487.1052 
                             2785 
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Histogram                                                   Quantiles                                                                                                           
 
 
 
 
 
 
Figure 41: Distribution of cost for the range $ 11,000.01 – $30,000.00 
 
 
 
      Histogram                                            Quantiles 
                                                                       
 
           
                      Moments 
  
Mean 55917.783 
Std Dev 35589.829 
Std Err Mean 2346.7238 
Upper 95% Mean 60541.714 
Lower 95% Mean 51293.852 
N 230 
 
Figure 42: Distribution of cost for the range $ 30,000.01 – $307,100.00 
 
 
 
    
100.0% maximum 29956 
99.5%  29738 
97.5%  28932 
90.0%  25144 
75.0% quartile 20939 
50.0% median 16392 
25.0% quartile 13201 
10.0%  11851 
2.5%  11194 
0.5%  11028 
0.0% 
 
Moments 
 
Mean 
Std Dev 
Std Err Mean 
Upper 95% Mean 
Lower 95% Mean 
N 
 
minimum 11009 
 
 
 
17518.162 
5007.077 
177.69451 
17866.969 
17169.354 
794 
 
    
100.0% maximum 307063 
99.5%  298575 
97.5%  154285 
90.0%  97739 
75.0% quartile 63980 
50.0% median 41818 
25.0% quartile 35372 
10.0%  31727 
2.5%  30155 
0.5%  30027 
0.0% minimum 30022 
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Appendix C. Cook’s Distance Plots for Models 2, 3, and 4 
 
 
Figure 43: Cook’s Distance Overlay Plot for Model 2  
 
 
 
Figure 44: Cook’s Distance Overlay Plot for Model 3 
 
 
  
Figure 45: Cook’s Distance Overlay Plot for Model 4 
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